Open in Screener

AIRS

Airsculpt Technologies Inc

Apr 09 • 11:10AM ET

2.66

-0.06 -2.37 %

Healthcare • Medical Care Facilities • USA • NASD

Peers: LGVN DERM HROW VRCA PMVP RCEL TVRD DBVT BKD CDTX

| Held by: IWM VTI VXF SCHA IWO VTWO IWN IWC VTWG RSSL

Index	RUT	P/E	-	EPS (ttm)	-0.19	Insider Own	91.19%	Shs Outstand	64.46M	Perf Week	-2.73%
Market Cap	187.32M	Forward P/E	-	EPS next Y	-0.03	Insider Trans	1.18%	Shs Float	6.22M	Perf Month	38.30%
Enterprise Value	264.43M	PEG	-	EPS next Q	-0.02	Inst Own	24.50%	Short Float	61.68%	Perf Quarter	23.51%
Income	-11.67M	P/S	1.23	EPS this Y	20.00%	Inst Trans	-3.65%	Short Ratio	1.35	Perf Half Y	-66.93%
Sales	151.82M	P/B	1.95	EPS next Y	25.00%	ROA	-5.87%	Short Interest	3.84M	Perf YTD	34.11%
Book/sh	1.36	P/C	22.17	EPS next 5Y	-	ROE	-13.97%	52W High	12.00 -77.87%	Perf Year	28.90%
Cash/sh	0.12	P/FCF	271.48	EPS past 3/5Y	9.87% -	ROIC	-7.36%	52W Low	1.51 75.85%	Perf 3Y	-42.77%
Dividend Est.	-	EV/EBITDA	20.71	Sales past 3/5Y	-3.47% 19.32%	Gross Margin	50.95%	Volatility	15.21% 17.43%	Perf 5Y	-
Dividend TTM	-	EV/Sales	1.74	EPS Y/Y TTM	-34.41%	Oper. Margin	-0.01%	ATR (14)	0.40	Perf 10Y	-
Dividend Ex-Date	Aug 25, 2022	Quick Ratio	0.55	Sales Y/Y TTM	-15.82%	Profit Margin	-7.68%	RSI (14)	50.27	Recom	2.00
Dividend Gr. 3/5Y	- -	Current Ratio	0.55	EPS Q/Q	122.98%	SMA20	-4.02%	Beta	2.20	Target Price	5.00
Payout	-	Debt/Eq	0.98	Sales Q/Q	-14.64%	SMA50	13.20%	Rel Volume	0.56	Prev Close	2.72
Employees	363	LT Debt/Eq	0.81	Earnings	Apr 02 BMO	SMA200	-45.16%	Avg Volume	2.84M	Price	2.66
IPO	Oct 29, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	20.00% -3.06%	Trades		Volume	463,864	Change	-2.37%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-17-24	Initiated	BTIG Research	Neutral
May-14-24	Downgrade	Leerink Partners	Outperform → Market Perform	$8.25 → $5
Nov-11-22	Downgrade	Piper Sandler	Overweight → Neutral	$4
Jun-16-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$17 → $8.50
Nov-23-21	Initiated	SVB Leerink	Outperform	$26
Nov-23-21	Initiated	Raymond James	Outperform	$18
Nov-23-21	Initiated	Piper Sandler	Overweight	$22
Nov-23-21	Initiated	Morgan Stanley	Overweight	$17

Apr-06-26 06:30AM	CORRECTION -- AirSculpt Technologies Reports Fourth Quarter and Full Year Fiscal 2025 Results (GlobeNewswire)
Apr-02-26 03:00PM	AirSculpt Technologies Inc (AIRS) Q1 2026 Earnings Call Highlights: Navigating Challenges with ... (GuruFocus.com) +16.12%
12:46PM	AirSculpt Technologies, Inc. Q4 2025 Earnings Call Summary (Moby)
06:30AM	AirSculpt Technologies Reports Fourth Quarter and Full Year Fiscal 2025 Results (GlobeNewswire)
Mar-31-26 05:09PM	AirSculpt Technologies Announces Fourth Quarter and Fiscal Year 2025 Earnings Release Date and Conference Call (GlobeNewswire)
06:45AM	Loading…
Mar-16-26 06:45AM	AirSculpt Technologies Announces Its Intent to Delay the Filing of its Annual Report and Provides Business Update (GlobeNewswire) +51.62%
Mar-06-26 01:00PM	Duolingo's AI-First Strategy & Data Secures Dominance in Ed-Tech (Zacks) +12.97%
Feb-24-26 10:45PM	Zeta Global Holdings (ZETA) Q4 Earnings and Revenues Top Estimates (Zacks)
Nov-17-25 05:32PM	AirSculpt Technologies Appoints Mike Doyle as Non-Executive Chairman of the Board (GlobeNewswire) -23.77%
Nov-07-25 07:15AM	AirSculpt Technologies, Inc. (AIRS) Reports Q3 Loss, Misses Revenue Estimates (Zacks) -41.66%
06:00AM	AirSculpt Technologies Reports Third Quarter Fiscal 2025 Results (GlobeNewswire)
Nov-06-25 07:24AM	What To Expect From AirSculpt Technologies Inc (AIRS) Q3 2025 Earnings (GuruFocus.com) +9.16%
Nov-05-25 06:25PM	Xperi (XPER) Q3 Earnings and Revenues Top Estimates (Zacks) +6.78%
Oct-31-25 06:45AM	AirSculpt Technologies Announces Third Quarter Fiscal 2025 Earnings Release Date and Conference Call (GlobeNewswire)
Oct-23-25 11:10AM	This Stock Makes You Look Good and It Just Hit New 3-Year Highs (Barchart)
09:40AM	Loading…
Sep-26-25 09:40AM	Are Business Services Stocks Lagging AirSculpt Technologies (AIRS) This Year? (Zacks)
Sep-19-25 12:00PM	Are You Looking for a Top Momentum Pick? Why AirSculpt Technologies, Inc. (AIRS) is a Great Choice (Zacks) +6.50%
Sep-03-25 12:00PM	AirSculpt Technologies (AIRS) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
Aug-19-25 08:00AM	Sidoti Events, LLC's Virtual August Micro-Cap Conference (ACCESSWIRE)
Aug-13-25 06:00AM	AirSculpt Technologies Announces Participation in Sidoti Micro Cap Conference (GlobeNewswire) +8.79%
Aug-08-25 09:40AM	Is AirSculpt Technologies (AIRS) Stock Outpacing Its Business Services Peers This Year? (Zacks)
Aug-02-25 03:07AM	AirSculpt Technologies Inc (AIRS) Q2 2025 Earnings Call Highlights: Navigating Challenges with ... (GuruFocus.com)
Aug-01-25 07:10AM	AirSculpt Technologies, Inc. (AIRS) Q2 Earnings Match Estimates (Zacks) -10.51%
06:00AM	AirSculpt Technologies Reports Second Quarter Fiscal 2025 Results (GlobeNewswire)
Jul-31-25 09:30AM	Earnings To Watch: AirSculpt Technologies Inc (AIRS) Reports Q2 2025 Result (GuruFocus.com) +7.65%
Jul-25-25 06:45AM	AirSculpt Technologies Announces Second Quarter Fiscal 2025 Earnings Release Date and Conference Call (GlobeNewswire)
Jul-02-25 02:39PM	AirSculpt Technologies (AIRS) Moves 8.7% Higher: Will This Strength Last? (Zacks)
Jun-16-25 06:45AM	AirSculpt Strengthens Balance Sheet with $10.0 Million Debt Paydown (GlobeNewswire) +11.21%
Jun-11-25 04:05PM	AirSculpt Announces Closing of Offering of Common Stock and Underwriters' Full Exercise of Option to Purchase Additional Shares (GlobeNewswire)
Jun-10-25 06:55AM	AirSculpt Announces Pricing of Offering of Common Stock (GlobeNewswire)
04:25PM	Loading…
Jun-09-25 04:25PM	AirSculpt Announces Public Offering of Common Stock (GlobeNewswire)
May-27-25 12:00PM	AirSculpt Technologies, Inc. (AIRS) is a Great Momentum Stock: Should You Buy? (Zacks)
May-03-25 03:02AM	AirSculpt Technologies Inc (AIRS) Q1 2025 Earnings Call Highlights: Navigating Challenges with ... (GuruFocus.com)
May-02-25 11:02PM	Q1 2025 AirSculpt Technologies Inc Earnings Call (Thomson Reuters StreetEvents) +33.63% -19.54%
01:12PM	AirSculpt Technologies, Inc. (AIRS) Q1 2025 Earnings Call Transcript (Seeking Alpha)
07:10AM	AirSculpt Technologies, Inc. (AIRS) Reports Q1 Loss (Zacks)
06:00AM	AirSculpt Technologies Reports First Quarter Fiscal 2025 Results and Full Year Guidance (GlobeNewswire)
May-01-25 09:32AM	What To Expect From AirSculpt Technologies Inc (AIRS) Q1 2025 Earnings (GuruFocus.com)
Apr-25-25 06:45AM	AirSculpt Technologies Announces First Quarter Fiscal 2025 Earnings Release Date and Conference Call (GlobeNewswire) +7.69%
Apr-17-25 05:27AM	New Strong Sell Stocks for April 17th (Zacks) +6.92%
Apr-14-25 07:18AM	New Strong Sell Stocks for April 14th (Zacks)
Apr-02-25 06:07AM	New Strong Sell Stocks for April 2nd (Zacks)
Apr-01-25 12:16PM	AirSculpt Technologies price target lowered to $2.50 from $6.50 at Leerink (TipRanks) -8.14%
Mar-26-25 05:33AM	New Strong Sell Stocks for March 26th (Zacks)
Mar-24-25 05:29AM	New Strong Sell Stocks for March 24th (Zacks)
Mar-15-25 03:02AM	AirSculpt Technologies Inc (AIRS) Q4 2024 Earnings Call Highlights: Navigating Challenges with ... (GuruFocus.com)
12:48AM	Q4 2024 Airsculpt Technologies Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-14-25 07:10AM	AirSculpt Technologies, Inc. (AIRS) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
06:00AM	AirSculpt Technologies Reports Fourth Quarter, and Full Year Fiscal 2024 Results (GlobeNewswire)
Mar-11-25 09:15AM	Unveiling AirSculpt Technologies (AIRS) Q4 Outlook: Wall Street Estimates for Key Metrics (Zacks) -11.45%
Mar-06-25 06:45AM	AirSculpt Technologies Announces Fourth Quarter Fiscal 2024 Earnings Release Date and Conference Call (GlobeNewswire)
Jan-13-25 06:45AM	AirSculpt Technologies Updates Fiscal Year 2024 Guidance in Advance of its Participation in the ICR Conference 2025 (GlobeNewswire) -19.90%
Jan-07-25 06:45AM	AirSculpt Technologies Announces Participation in the ICR Conference 2025 (GlobeNewswire)
Dec-17-24 06:45AM	AirSculpt Technologies Names Yogi Jashnani Chief Executive Officer (GlobeNewswire) +5.18%
Dec-10-24 10:42PM	Why Is AirSculpt Technologies Inc. (AIRS) Among the Best Cosmetic Surgery and Aesthetics Stocks to Invest In Now? (Insider Monkey) -5.67%
Dec-02-24 01:22PM	AirSculpt Technologies, Inc. Announces Opening of Its New White Plains, NY Center (PR Newswire)
Nov-09-24 02:04AM	AirSculpt Technologies Inc (AIRS) Q3 2024 Earnings Call Highlights: Navigating Challenges with ... (GuruFocus.com)
01:34AM	Q3 2024 Airsculpt Technologies Inc Earnings Call (Thomson Reuters StreetEvents)
Nov-08-24 09:30AM	AirSculpt Technologies (AIRS) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks) +20.72%
07:10AM	AirSculpt Technologies, Inc. (AIRS) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
06:00AM	AirSculpt Technologies Reports Third Quarter Fiscal 2024 Results (GlobeNewswire)
Nov-07-24 07:09AM	What To Expect From AirSculpt Technologies Inc (AIRS) Q3 2024 Earnings (GuruFocus.com) -6.14%
Nov-05-24 11:17AM	AirSculpt Technologies (AIRS) Moves 14.2% Higher: Will This Strength Last? (Zacks)
Oct-24-24 06:30AM	AirSculpt Technologies Announces Preliminary Third Quarter 2024 Revenue Results (GlobeNewswire) +5.26%
Oct-15-24 08:05AM	AirSculpt Technologies (AIRS) Surges 5.6%: Is This an Indication of Further Gains? (Zacks)
Oct-01-24 12:48PM	AirSculpt Technologies, Inc. Announces Opening of Its New Center in Birmingham, MI (PR Newswire) -6.31%
Sep-24-24 01:30PM	AirSculpt Technologies, Inc. Adds New Center In Deerfield, IL To Meet Chicago Market Demand (PR Newswire) +7.34%
Sep-19-24 08:32AM	Do Options Traders Know Something About AirSculpt Technologies (AIRS) Stock We Don't? (Zacks) +6.77%
Aug-23-24 08:30AM	Implied Volatility Surging for AirSculpt Technologies (AIRS) Stock Options (Zacks)
Aug-19-24 12:00PM	AirSculpt Technologies, Inc. Announces Opening of Its New Center in Columbus, OH (PR Newswire)
Aug-10-24 08:18AM	AirSculpt Technologies, Inc. (NASDAQ:AIRS) Q2 2024 Earnings Call Transcript (Insider Monkey)
Aug-09-24 10:52AM	AIRS Stock Earnings: AirSculpt Technologies Beats EPS, Misses Revenue for Q2 2024 (InvestorPlace)
09:30AM	Here's What Key Metrics Tell Us About AirSculpt Technologies (AIRS) Q2 Earnings (Zacks)
07:25AM	AirSculpt Technologies, Inc. (AIRS) Q2 Earnings and Revenues Miss Estimates (Zacks)
06:33AM	AirSculpt Technologies, Inc. (AIRS): The Best Cosmetic Surgery and Aesthetics Stocks To Buy? (Insider Monkey)
06:10AM	AirSculpt Technologies Reports Second Quarter Fiscal 2024 Results (GlobeNewswire)
06:00AM	AirSculpt Technologies Announces Leadership Changes (GlobeNewswire)
Aug-07-24 09:15AM	Ahead of AirSculpt Technologies (AIRS) Q2 Earnings: Get Ready With Wall Street Estimates for Key Metrics (Zacks)
Jul-25-24 06:45AM	AirSculpt Technologies Announces Second Quarter Fiscal 2024 Earnings Release Date and Conference Call (GlobeNewswire)
Jul-15-24 11:57AM	7 Short-Squeeze Stocks That Could Beat Down the Bears (InvestorPlace)
Jun-17-24 06:00AM	3 Short-Squeeze Stocks to Buy Before July for 20% Returns (InvestorPlace)
May-31-24 09:36AM	Do Options Traders Know Something About AirSculpt (AIRS) Stock We Don't? (Zacks)
May-24-24 09:55AM	Here's Why AirSculpt Technologies (AIRS) Could be Great Choice for a Bottom Fisher (Zacks)
09:35AM	Down -38.41% in 4 Weeks, Here's Why AirSculpt Technologies (AIRS) Looks Ripe for a Turnaround (Zacks)
May-13-24 03:06AM	AirSculpt Technologies Inc (AIRS) Q1 2024 Earnings Call Transcript Highlights: Navigating ... (GuruFocus.com)
May-11-24 10:19AM	AirSculpt Technologies, Inc. (NASDAQ:AIRS) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-10-24 03:32PM	AirSculpt Technologies Inc (AIRS) Exceeds First Quarter Revenue Estimates with Strong Performance (GuruFocus.com) -12.06%
01:48PM	AirSculpt Technologies Shares Down After Q1 Adjusted Earnings Fall (MT Newswires)
10:53AM	AIRS Stock Earnings: AirSculpt Technologies Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace)
09:30AM	Compared to Estimates, AirSculpt Technologies (AIRS) Q1 Earnings: A Look at Key Metrics (Zacks)
07:15AM	AirSculpt Technologies, Inc. (AIRS) Lags Q1 Earnings and Revenue Estimates (Zacks)
06:00AM	AirSculpt Technologies Reports for First Quarter Earnings (GlobeNewswire)
May-08-24 09:15AM	Countdown to AirSculpt Technologies (AIRS) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS (Zacks)
Apr-30-24 07:00AM	AirSculpt Technologies Announces First Quarter 2024 Earnings Release Date and Conference Call (GlobeNewswire)
Apr-29-24 08:30AM	AirSculpt Relocates and Expands to New Location to Meet Market Demand (PR Newswire)
Mar-19-24 08:30AM	AirSculpt Announces Kristen Doute, Star of Bravo's The Valley As Latest AirSculpt Client (PR Newswire)
Mar-18-24 07:00AM	Bear of the Day: AirSculpt (AIRS) (Zacks)
Mar-12-24 03:59PM	Short-Squeeze Showdown: 3 Stocks Ready to Crush the Skeptics (InvestorPlace)
Mar-10-24 10:18AM	10 Botox Alternatives for Smoothing Wrinkles and Anti-Aging Treatment (Insider Monkey)
Mar-07-24 07:00AM	AirSculpt Technologies Announces Participation at BofA Securities Consumer and Retail Conference (GlobeNewswire)

AirSculpt Technologies, Inc. is a fat removal treatment under its brand, Elite Body Sculpture.. It provides custom body contouring using proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure, producing dramatic results. The company was founded by Aaron J. Rollins in 2012 and is headquartered in Miami Beach, FL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Chernett Jorey	10% Owner	Apr 07 '26	Buy	2.93	60,000	175,800	6,993,761	Apr 08 09:09 AM
Chernett Jorey	10% Owner	Apr 03 '26	Buy	2.82	90,000	253,800	6,933,761	Apr 06 09:34 AM
Chernett Jorey	10% Owner	Mar 23 '26	Buy	2.91	50,000	145,500	6,843,761	Mar 25 01:43 PM
Chernett Jorey	10% Owner	Mar 20 '26	Buy	2.77	40,000	110,800	6,793,761	Mar 23 09:33 AM
Chernett Jorey	10% Owner	Mar 19 '26	Buy	2.64	77,702	205,133	6,753,761	Mar 20 09:33 AM
Chernett Jorey	10% Owner	Mar 17 '26	Buy	2.56	83,000	212,480	6,676,059	Mar 18 10:36 AM
Chernett Jorey	10% Owner	Mar 16 '26	Buy	2.43	105,848	257,211	6,592,059	Mar 16 06:43 PM
Chernett Jorey	10% Owner	Mar 11 '26	Buy	2.15	88,000	189,200	6,486,211	Mar 11 05:30 PM
Chernett Jorey	10% Owner	Mar 06 '26	Buy	2.00	45,600	91,200	6,398,211	Mar 09 08:40 AM
Chernett Jorey	10% Owner	Mar 03 '26	Buy	1.71	80,000	136,800	6,322,611	Mar 04 06:58 PM
Chernett Jorey	10% Owner	Mar 04 '26	Buy	1.87	30,000	56,100	6,352,611	Mar 04 06:58 PM
Feinstein Adam T	Director	Jun 09 '25	Buy	4.00	1,000,000	4,000,000	14,038,819	Jun 11 05:06 PM
Rollins Aaron	Executive Chairman	May 19 '25	Buy	3.60	2,118	7,629	15,146,039	May 20 04:11 PM
Jashnani Yogesh	Chief Executive Officer	May 07 '25	Buy	2.65	7,000	18,532	464,879	May 07 05:56 PM

HIMS Hims & Hers Health Inc daily Stock Chart

Peers: ELF LFMD PRGO TDOC GDRX AMWL DOCS CLOV RXRX TWST

| Held by: IJH VTI IWM VB VBK IWO VXF MDY IJK SPMD

Index	RUT	P/E	36.54	EPS (ttm)	0.52	Insider Own	9.16%	Shs Outstand	218.87M	Perf Week	-3.86%
Market Cap	4.35B	Forward P/E	29.27	EPS next Y	0.65	Insider Trans	-1.23%	Shs Float	207.07M	Perf Month	-18.73%
Enterprise Value	4.89B	PEG	1.03	EPS next Q	0.03	Inst Own	81.04%	Short Float	40.22%	Perf Quarter	-46.21%
Income	128.37M	P/S	1.85	EPS this Y	0.69%	Inst Trans	-14.49%	Short Ratio	2.38	Perf Half Y	-67.10%
Sales	2.35B	P/B	8.01	EPS next Y	26.90%	ROA	8.92%	Short Interest	83.29M	Perf YTD	-41.25%
Book/sh	2.38	P/C	7.53	EPS next 5Y	28.51%	ROE	25.23%	52W High	70.43 -72.92%	Perf Year	-35.32%
Cash/sh	2.53	P/FCF	75.73	EPS past 3/5Y	- -	ROIC	7.75%	52W Low	13.74 38.83%	Perf 3Y	91.71%
Dividend Est.	-	EV/EBITDA	27.76	Sales past 3/5Y	64.55% 73.63%	Gross Margin	60.86%	Volatility	6.72% 8.57%	Perf 5Y	47.07%
Dividend TTM	-	EV/Sales	2.08	EPS Y/Y TTM	-1.56%	Oper. Margin	5.18%	ATR (14)	1.71	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.61	Sales Y/Y TTM	59.00%	Profit Margin	5.47%	RSI (14)	43.70	Recom	2.42
Dividend Gr. 3/5Y	- -	Current Ratio	1.90	EPS Q/Q	-17.39%	SMA20	-11.17%	Beta	2.35	Target Price	25.36
Payout	0.00%	Debt/Eq	2.07	Sales Q/Q	28.41%	SMA50	-6.10%	Rel Volume	0.47	Prev Close	19.39
Employees	2442	LT Debt/Eq	2.06	Earnings	Feb 23 AMC	SMA200	-51.15%	Avg Volume	34.92M	Price	19.08
IPO	Sep 13, 2019	Option/Short	Yes / Yes	EPS/Sales Surpr.	100.50% -0.23%	Trades		Volume	4,777,636	Change	-1.62%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-10-26	Upgrade	Citigroup	Sell → Neutral	$24
Mar-10-26	Upgrade	BofA Securities	Underperform → Neutral	$23
Mar-09-26	Upgrade	Needham	Hold → Buy	$30
Feb-24-26	Downgrade	BTIG Research	Buy → Neutral
Jan-12-26	Initiated	Evercore ISI	In-line	$33
Dec-09-25	Initiated	Barclays	Overweight	$48
Oct-21-25	Initiated	KeyBanc Capital Markets	Sector Weight
Jun-23-25	Downgrade	Needham	Buy → Hold
Jun-04-25	Reiterated	Needham	Buy	$61 → $65
Apr-29-25	Downgrade	TD Cowen	Buy → Hold	$30
Feb-18-25	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$42 → $60
Jan-10-25	Downgrade	Citigroup	Neutral → Sell	$24 → $25
Jan-07-25	Initiated	BTIG Research	Buy	$35
Dec-17-24	Initiated	Morgan Stanley	Overweight	$42
Nov-14-24	Downgrade	BofA Securities	Buy → Underperform
Aug-22-24	Initiated	Needham	Buy	$24
Aug-09-24	Downgrade	Imperial Capital	Outperform → In-line
May-22-24	Downgrade	Citigroup	Buy → Neutral	$16 → $20
Apr-16-24	Downgrade	Jefferies	Buy → Hold	$17 → $15
Apr-10-24	Initiated	Canaccord Genuity	Buy	$20

Show Previous Ratings

Apr-08-26 12:25PM	Hims & Hers price target slashed amid GLP-1 transition (Proactive)
02:00AM	New Derivative Income ETFs Aren't Worth the Risks (Barrons.com)
Apr-07-26 05:47PM	The $190 Billion 'Diabesity' Market Is Set to Explode. Lilly and Novo Face These Stock Catalysts. (Barrons.com)
Apr-06-26 06:38AM	Hims & Hers says limited data stolen in social engineering attack (Cybersecurity Dive) +6.22%
Apr-01-26 09:46AM	Disney upgraded, Nike downgraded: Wall Street's top analyst calls (The Fly)
09:15AM	Loading…
Mar-31-26 09:15AM	Novo Nordisk launches Wegovy subscription program (Quartz) +10.54%
Mar-26-26 12:00PM	Novo Nordisk's FDA-Approved GLP-1s Now Available With Hims & Hers (Business Wire)
Mar-19-26 02:42PM	A high dose of Wegovy helped people lose 21% of their weight. It was just approved. (MarketWatch)
Mar-13-26 04:45PM	Hims Shares Notch Record Week as Novo Pact Spurs Optimism (Bloomberg)
Mar-12-26 02:50PM	Hims & Hers Stock Jumps After Novo Nordisk Deal. What It Means for Drugmaker (GuruFocus.com) -7.88%
10:57AM	Should You Chase the Rally in Hims & Hers Stock Today? (Barchart)
Mar-11-26 02:28PM	Hims & Hers Hires Ex-Eli Lilly Communications Chief Amid Obesity Drug Strategy Shift (GuruFocus.com) +10.27%
02:25PM	Hims & Hers C-suite shake-up, Stryker outage may be Iran-backed (Yahoo Finance Video)
12:38PM	Hims & Hers Brings In Lilly Communications Veteran (GuruFocus.com)
05:05AM	Hims & Hers price target raised to $29 from $25 at Barclays (TipRanks)
08:08PM	Loading…
Mar-10-26 08:08PM	Hims & Hers Names Kathryn Beiser as Chief Communications Officer (Business Wire) +5.91%
03:02PM	What's Driving Attention Behind These Trending Stocks? MRVL, STRL, HIMS (Zacks)
02:42PM	Hims & Hers Stock Upgraded After Novo Nordisk Agreement. Why It Isn't a Buy Yet. (Barrons.com)
02:03PM	Patience Pays: Hims & Hers Surges on News of Novo Nordisk Deal (MarketBeat)
01:33PM	Hims and Hers Expands Consumer-Focused Digital Health Platform (Zacks)
01:01PM	What's Fueling The Rise In Hims & Hers Health Stock Today? (Benzinga)
12:05PM	Wall Street Gets Less Bearish on Hims & Hers After Novo Nordisk Truce. Stock Gains Could Still Be Limited. (Barrons.com)
10:09AM	Wall Street Turns Bullish on HIMS, TDOC and ALEC as Partnerships Reshape Risk Profiles (24/7 Wall St.)
09:00AM	Hims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
09:00AM	Introducing Hims & Hers Benefits, Unlocking Health & Wellness Discounts for Subscribers (Business Wire)
08:06AM	Here Are Tuesday's Top Wall Street Analyst Research Calls: AT&T, Amgen, CrowdStrike, Gilead, Hims & Hers, Intuit, Lowe's,Qualcomm, Rivian, Strategy and More (24/7 Wall St.)
07:40AM	Novo and Hims & Hers become partners to end legal feud (Pharmaceutical Technology)
07:06AM	Trump Soothes Market's Iran Fears. Why the Threat's Not Over for Stocks, Oil. (Barrons.com)
Mar-09-26 09:19PM	Hims & Hers, Roku, Oracle, Autozi And Joby Aviation: Why These 5 Stocks Are On Investors' Radars Today (Benzinga) +40.79%
07:08PM	Analyst Report: Hims & Hers Health, Inc. (Morningstar Research)
04:38PM	Loading…
04:38PM	Stocks Close Higher After President Trump says Iran War is "Pretty Much" Complete (Barchart)
04:31PM	Stock Market Today: Dow Gains As Trump Says Iran War Is 'Very Complete'; Cruise Stock Soars (Live Coverage) (Investor's Business Daily)
04:25PM	Hims & Hers Catapults After Settling Its Bloody Saga With Novo Nordisk (Investor's Business Daily)
04:18PM	Uber expands Women Preferences, Hims & Hers stock skyrockets (Yahoo Finance Video)
04:02PM	Novo Nordisk deal lets Hims sell Wegovy and Ozempic, drops lawsuit (USA TODAY)
03:32PM	Hims & Novo Call a Truce, Hims Gets Exactly What It Wanted (Moby)
03:30PM	Hims & Hers rockets higher on potential Novo Nordisk deal (GuruFocus.com)
03:23PM	Stock Of The Day: Will Hims & Hers Go Into Another Short Squeeze? (Benzinga)
02:54PM	Hims & Hers Jumps 47% as Novo Nordisk Weighs New Weight-Loss Drug Partnership (GuruFocus.com)
02:34PM	Nasdaq stays green as Middle East war sends oil above $103 (Proactive)
02:27PM	Hims and Novo End Feud With Obesity Drug Deal (GuruFocus.com)
01:18PM	Novo Nordisk strikes deal for Hims to sell Wegovy and Ozempic (Reuters Videos)
01:17PM	Hims & Hers Shares Surge on Novo Nordisk Deal Report (GuruFocus.com)
01:11PM	Hims & Hers stock skyrockets 40% as Novo Nordisk ends feud, agrees to sell Ozempic and Wegovy on platform (MarketWatch)
01:10PM	These Stocks Are Today's Movers: Hims & Hers, Live Nation, Carnival, Delta, Vertiv, Sandisk, Strategy, and More (Barrons.com)
12:51PM	Hims & Hers Stock Jumps on Reports Novo Nordisk Obesity Deal (GuruFocus.com)
12:15PM	Hims & Hers Stock Soars. Its Weight-Loss Drug Battle With Novo Nordisk Takes a Surprising Twist. (Barrons.com)
11:45AM	Why Hims & Hers Health (HIMS) Stock Is Up Today (StockStory)
11:16AM	Pre-Markets in the Red as Geopolitical Tensions Escalate (Zacks)
11:13AM	Hims partners with Novo Nordisk, Live Nation settles antitrust suit (Yahoo Finance Video)
11:08AM	Hims & Hers stock surges as Novo Nordisk says it will distribute weight-loss drugs on platform (Yahoo Finance)
11:04AM	Hims & Hers partners with Novo Nordisk to sell Wegovy and Ozempic, ending dispute (Proactive)
10:35AM	HIMS Stock Eyes Best Day Ever After Dispute Dissolution (Schaeffer's Research)
10:18AM	Hims & Hers Health and Novo Nordisk end lawsuit over weight loss medications, enter collaboration (Associated Press Finance)
10:17AM	Pre-Markets Down as Middle East Tensions Remain (Zacks)
10:01AM	Hims & Hers agrees to stop selling compound versions of Novo Nordisk's Wegovy and other weight-loss drugs, ending suit (Associated Press Finance)
09:58AM	Live Nasdaq Composite: Market Turmoil Persists With All Eyes On $100 Oil (24/7 Wall St.)
09:52AM	Novo Nordisk to Sell Weight-Loss Drugs Through Hims & Hers (The Wall Street Journal)
09:38AM	Hims & Hers Stock Pops on a Deal With Rival Novo NordiskWhat You Need to Know (Investopedia)
09:35AM	Hims & Hers Stock Surges as Novo Nordisk Deal Ends Legal Dispute (The Wall Street Journal)
09:34AM	Hims And Hers Surges 40% On Deal To Sell Novo Nordisk Obesity Drugs (Investor's Business Daily)
09:02AM	Hims & Hers will sell real Ozempic in deal with Novo Nordisk (Quartz)
08:53AM	Novo Nordisk to Sell Weight-Loss Drugs Through Hims & Hers Platform (The Wall Street Journal)
08:30AM	Hims & Hers Announces Strategic Shift for US Weight Loss Business (Business Wire)
07:42AM	Stocks to Watch Monday: Moderna, Live Nation, Pfizer, Hims & Hers (The Wall Street Journal)
07:04AM	Hims & Hers, Novo Nordisk Weight-Loss Drug Deal Ends Legal Feud, Stock Soars (Benzinga)
07:00AM	Hims And Hers Surges Over 50% On Deal To Sell Novo Nordisk Obesity Drugs (Investor's Business Daily)
06:25AM	These Stocks Are Todays Movers: Chevron, Hims & Hers, Carnival, Delta, Newmont, Vertiv, and More (Barrons.com)
06:06AM	Hims & Hers Shares Double on Report of Wegovy Tie-Up (The Wall Street Journal)
05:43AM	Stocks to Watch Monday: Lamb Weston, Carnival, Pfizer, Hims & Hers (The Wall Street Journal)
05:34AM	Hims soars 44% on report Novo Nordisk to sell weight-loss drugs on its platform (Investing.com)
05:28AM	Stock Market Today: Dow Jones, S&P 500 Futures Plunge As Oil Prices Jump, Trump Dismisses 'Short Term' Spike-Hims & Hers, Ovintiv, Uniqure In Focus (Benzinga)
Mar-07-26 10:56AM	Hims & Hers Surprise Rescue: Stock Explodes 40% on GLP-1 Truce (24/7 Wall St.)
Mar-06-26 09:52PM	Novo Nordisk And Hims & Hers End Bitter Legal Feud With Surprise Weight-Loss Drug Deal: Report (Benzinga) +40.79%
Mar-05-26 03:28PM	Barclays Lowers its Price Target on Hims & Hers Health, Inc. (HIMS) to $25 and Keeps an Overweight Rating (Insider Monkey)
09:35AM	Hims and Hers Expands Its Technology Driven Consumer Health Platform (Zacks)
Mar-04-26 12:18PM	Hims & Hers Slips as FDA Targets GLP-1 Compounders (GuruFocus.com)
02:30AM	Canaccord Lowers Hims & Hers Health, Inc. (HIMS) Price Target Patent Amid Dispute and FDA Scrutiny (Insider Monkey)
Mar-03-26 11:06AM	EXCLUSIVE: Top 12 Most-Searched Tickers On Benzinga Pro In February - Where Do Tesla, Nvidia, Palantir Stocks Rank? (Benzinga)
Mar-02-26 01:01PM	What's Behind The Jump In Hims & Hers Health Stock? (Benzinga) +13.50%
09:16AM	Analysis-Hims expansion may not come in time for risky GLP-1 business (Reuters)
Feb-27-26 12:39PM	Hims & Hers Expands Digital Health and Global Platform Strategy (Zacks) -6.92%
09:00AM	Investors Heavily Search Hims & Hers Health, Inc. (HIMS): Here is What You Need to Know (Zacks)
Feb-25-26 12:40PM	HIMS vs. AMWL: Which Telehealth Stock Is the Better Investment Now? (Zacks)
Feb-24-26 08:41PM	Stocks to Watch Tuesday Recap: Workday, Home Depot, Paramount, FedEx (The Wall Street Journal)
04:35PM	These Stocks Are Todays Movers: AMD, Hims & Hers, Keysight, IBM, Kratos, Vir Biotechnology, Whirlpool, and More (Barrons.com)
03:21PM	Stocks to Watch Tuesday: Home Depot, Paramount, JP Morgan, FedEx (The Wall Street Journal)
02:14PM	Hims & Hers Stock Faces Heavy Sell-Off Amid SEC Probe Into GLP-1 Disclosures (GuruFocus.com)
12:15PM	Hims & Hers Stock Slips Despite Q4 Earnings Beat, Margins Contract (Zacks)
10:09AM	Hims & Hers Stock Drops. Why Earnings Are Underwhelming Investors. (Barrons.com)
09:59AM	Stocks Rebound as Software Stocks Recover (Barchart)
09:55AM	Meta, AMD announce chip partnership, Novo Nordisk cuts US GLP-1 prices (Yahoo Finance Video)
09:39AM	Qualcomm, Booking Holdings upgraded: Wall Street's top analyst calls (The Fly)
09:24AM	Hims & Hers Stumbles at the Open as Regulatory Damage Hits 2026 Outlook Hard (24/7 Wall St.)
08:32AM	Hims & Hers Stock Stumbles - Cautions About Pressure Due To Super Bowl Ad, Change In Shipping Cadences (Benzinga)
07:55AM	Earnings live: Home Depot stock climbs after earnings beat, Hims & Hers slides, Constellation Energy rises (Yahoo Finance)
07:53AM	Stocks to Watch Tuesday: FedEx, Home Depot, Novo Nordisk (The Wall Street Journal)
06:40AM	Hims & Hers Snaps EPS Losing Streak but Shares Still in Free Fall (24/7 Wall St.)
06:29AM	Stock Index Futures Mixed With Focus on Trumps SOTU Address and U.S. Economic Data (Barchart)
06:22AM	Hims & Hers Q4 EPS Beats; Soft 2026 Outlook (GuruFocus.com)

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Okupe Oluyemi	Chief Financial Officer	Apr 06 '26	Option Exercise	5.01	3,975	19,915	322,764	Apr 07 05:14 PM
Okupe Oluyemi	Chief Financial Officer	Apr 06 '26	Sale	19.98	3,975	79,409	318,789	Apr 07 05:14 PM
Oluyemi Okupe	Officer	Apr 06 '26	Proposed Sale	20.33	240,560	4,890,585		Apr 06 06:03 PM
Okupe Oluyemi	Chief Financial Officer	Mar 20 '26	Option Exercise	5.01	4,489	22,490	328,006	Mar 24 06:09 PM
Okupe Oluyemi	Chief Financial Officer	Mar 20 '26	Sale	23.77	9,217	219,067	318,789	Mar 24 06:09 PM
Becklund Irene	PAO	Mar 17 '26	Sale	24.69	5,529	136,511	8,752	Mar 18 04:17 PM
Boughton Soleil	Chief Legal Officer	Mar 17 '26	Sale	24.69	4,812	118,808	308,831	Mar 18 04:17 PM
Chi Michael	Chief Operating Officer	Mar 17 '26	Sale	24.69	97,289	2,402,065	407,282	Mar 18 04:17 PM
Boughton Soleil	Officer	Mar 17 '26	Proposed Sale	24.69	4,812	118,808		Mar 17 12:41 PM
Becklund Irene	Officer	Mar 17 '26	Proposed Sale	24.69	5,529	136,511		Mar 17 11:39 AM
Chi Michael	Officer	Mar 17 '26	Proposed Sale	24.69	97,289	2,402,065		Mar 17 10:06 AM
Boughton Soleil	Chief Legal Officer	Feb 27 '26	Sale	15.21	4,651	70,742	440,972	Mar 02 04:18 PM
Boughton Soleil	Officer	Feb 27 '26	Proposed Sale	15.21	4,651	70,742		Feb 27 10:09 AM
Okupe Oluyemi	Chief Financial Officer	Feb 03 '26	Option Exercise	5.01	5,262	26,363	96,879	Feb 04 04:13 PM
Okupe Oluyemi	Chief Financial Officer	Feb 03 '26	Sale	26.44	5,262	139,108	91,617	Feb 04 04:13 PM
Okupe Oluyemi	Chief Financial Officer	Jan 20 '26	Option Exercise	6.27	9,067	56,836	100,684	Jan 21 04:23 PM
Okupe Oluyemi	Chief Financial Officer	Jan 20 '26	Sale	30.34	9,067	275,114	91,617	Jan 21 04:23 PM
Oluyemi Okupe	Officer	Jan 20 '26	Proposed Sale	30.47	27,204	828,906		Jan 20 04:34 PM
Okupe Oluyemi	Chief Financial Officer	Jan 05 '26	Option Exercise	9.16	5,986	54,818	100,687	Jan 07 04:16 PM
Okupe Oluyemi	Chief Financial Officer	Jan 05 '26	Sale	33.79	9,070	306,453	91,617	Jan 07 04:16 PM
Okupe Oluyemi	Chief Financial Officer	Dec 22 '25	Sale	35.72	23,090	824,710	94,333	Dec 23 04:15 PM
Oluyemi Okupe	Officer	Dec 22 '25	Proposed Sale	35.05	32,160	1,127,208		Dec 22 05:00 PM
Chi Michael	Chief Operating Officer	Dec 17 '25	Sale	36.71	13,750	504,762	305,161	Dec 18 04:15 PM
Autor Deborah M.	Chief Policy Officer	Dec 17 '25	Sale	36.71	7,054	258,952	6,175	Dec 18 04:15 PM
Carroll Patrick Harrison	Chief Medical Officer	Dec 17 '25	Sale	36.71	10,021	367,871	169,940	Dec 18 04:15 PM
Becklund Irene	PAO	Dec 17 '25	Sale	36.71	8,411	308,768	2,126	Dec 18 04:15 PM
Carroll Patrick Harrison	Officer	Dec 17 '25	Proposed Sale	36.71	10,021	367,871		Dec 17 10:26 AM
Chi Michael	Officer	Dec 17 '25	Proposed Sale	36.71	13,750	504,762		Dec 17 10:14 AM
Becklund Irene	Officer	Dec 17 '25	Proposed Sale	36.71	8,411	308,768		Dec 17 09:50 AM
Autor Deborah M.	Officer	Dec 17 '25	Proposed Sale	36.71	7,054	258,952		Dec 17 09:42 AM
Perez Garcia Andrea G	Director	Dec 09 '25	Sale	39.17	2,500	97,925	80,166	Dec 10 04:35 PM
Perez Garcia Andrea G	Director	Dec 09 '25	Proposed Sale	39.17	2,500	97,925		Dec 09 10:07 AM
Boughton Soleil	Chief Legal Officer	Nov 24 '25	Sale	35.22	2,631	92,664	153,225	Nov 25 04:13 PM
Boughton Soleil	Officer	Nov 24 '25	Proposed Sale	35.11	2,631	92,374		Nov 24 10:03 AM
Okupe Oluyemi	Chief Financial Officer	Nov 17 '25	Option Exercise	7.15	23,187	165,817	93,419	Nov 19 04:31 PM
Okupe Oluyemi	Chief Financial Officer	Nov 17 '25	Sale	36.81	23,187	853,490	70,232	Nov 19 04:31 PM
Boughton Soleil	Chief Legal Officer	Nov 10 '25	Sale	42.53	2,637	112,152	155,856	Nov 12 08:02 PM
Boughton Soleil	Officer	Nov 10 '25	Proposed Sale	42.53	2,637	112,152		Nov 10 10:16 AM
Boughton Soleil	Chief Legal Officer	Oct 27 '25	Sale	50.10	2,637	132,114	158,493	Oct 28 04:23 PM
Boughton Soleil	Officer	Oct 27 '25	Proposed Sale	50.10	2,637	132,114		Oct 27 09:42 AM
Okupe Oluyemi	Chief Financial Officer	Oct 17 '25	Option Exercise	7.15	11,592	82,898	81,824	Oct 20 04:42 PM
Okupe Oluyemi	Chief Financial Officer	Oct 17 '25	Sale	57.13	11,592	662,222	70,232	Oct 20 04:42 PM
Dudum Andrew	Officer	Oct 16 '25	Proposed Sale	62.79	175,661	11,029,998		Oct 16 03:10 PM
Chi Michael	Chief Commercial Officer	Oct 10 '25	Option Exercise	6.82	900	6,138	292,339	Oct 14 04:17 PM
Chi Michael	Chief Commercial Officer	Oct 10 '25	Sale	58.25	900	52,425	291,439	Oct 14 04:17 PM
Boughton Soleil	Chief Legal Officer	Oct 13 '25	Sale	54.38	2,637	143,400	161,130	Oct 14 04:17 PM
Boughton Soleil	Officer	Oct 13 '25	Proposed Sale	54.38	2,637	143,400		Oct 14 06:47 AM
Chi Michael	Officer	Oct 10 '25	Proposed Sale	58.25	900	52,425		Oct 10 11:26 AM
Okupe Oluyemi	Chief Financial Officer	Oct 03 '25	Option Exercise	7.15	11,595	82,919	81,827	Oct 07 04:47 PM
Okupe Oluyemi	Chief Financial Officer	Oct 03 '25	Sale	57.72	11,595	669,232	70,232	Oct 07 04:47 PM
Chi Michael	Chief Commercial Officer	Oct 01 '25	Option Exercise	11.53	250	2,882	291,689	Oct 02 04:10 PM
Chi Michael	Chief Commercial Officer	Oct 01 '25	Sale	56.00	250	14,000	291,439	Oct 02 04:10 PM
Chi Michael	Officer	Oct 01 '25	Proposed Sale	56.00	250	14,000		Oct 01 11:34 AM
Okupe Oluyemi	Chief Financial Officer	Sep 29 '25	Option Exercise	5.01	49,832	249,658	155,232	Sep 30 04:33 PM
Okupe Oluyemi	Chief Financial Officer	Sep 29 '25	Sale	60.20	85,000	5,116,924	70,232	Sep 30 04:33 PM
Boughton Soleil	Chief Legal Officer	Sep 29 '25	Sale	58.79	2,637	155,029	163,767	Sep 30 04:33 PM
Boughton Soleil	Officer	Sep 29 '25	Proposed Sale	58.79	2,637	155,029		Sep 29 09:51 AM
Chi Michael	Chief Commercial Officer	Sep 24 '25	Option Exercise	5.01	2,100	10,521	293,539	Sep 25 06:06 PM
Chi Michael	Chief Commercial Officer	Sep 24 '25	Sale	56.52	2,100	118,692	291,439	Sep 25 06:06 PM
Okupe Oluyemi	Chief Financial Officer	Sep 22 '25	Sale	57.74	23,584	1,361,766	105,400	Sep 24 04:22 PM
Chi Michael	Officer	Sep 24 '25	Proposed Sale	56.52	2,100	118,692		Sep 24 11:02 AM
Oluyemi Okupe	Officer	Sep 22 '25	Proposed Sale	57.70	154,958	8,941,077		Sep 22 05:39 PM
Boughton Soleil	Chief Legal Officer	Sep 17 '25	Sale	50.50	2,637	133,168	166,404	Sep 19 04:28 PM
Carroll Patrick Harrison	Chief Medical Officer	Sep 17 '25	Sale	50.50	10,021	506,060	169,940	Sep 19 04:28 PM
Becklund Irene	PAO	Sep 17 '25	Sale	50.50	8,410	424,705	1,418	Sep 19 04:28 PM
Chi Michael	Chief Commercial Officer	Sep 17 '25	Sale	50.50	13,749	694,324	297,139	Sep 19 04:27 PM
Dudum Andrew	Chief Executive Officer	Sep 17 '25	Sale	50.57	65,110	3,292,906	95,315	Sep 19 04:27 PM
Chi Michael	Chief Commercial Officer	Sep 15 '25	Option Exercise	6.19	4,150	25,680	282,804	Sep 17 07:24 PM
Chi Michael	Chief Commercial Officer	Sep 15 '25	Sale	56.00	4,150	232,400	278,654	Sep 17 07:24 PM
Dudum Andrew	Chief Executive Officer	Sep 16 '25	Option Exercise	2.43	125,335	304,564	268,759	Sep 17 07:24 PM
Dudum Andrew	Chief Executive Officer	Sep 16 '25	Sale	53.48	128,127	6,852,300	160,425	Sep 17 07:24 PM
Dudum Andrew	Chief Executive Officer	Sep 16 '25	Sale	53.27	47,534	2,532,325	95,058	Sep 17 07:24 PM
Okupe Oluyemi	Chief Financial Officer	Sep 15 '25	Option Exercise	5.01	110,000	551,100	273,984	Sep 17 07:24 PM
Okupe Oluyemi	Chief Financial Officer	Sep 15 '25	Sale	55.35	145,000	8,026,076	128,984	Sep 17 07:24 PM
Dudum Andrew	Officer	Sep 17 '25	Proposed Sale	50.57	65,110	3,292,904		Sep 17 12:44 PM
Boughton Soleil	Officer	Sep 17 '25	Proposed Sale	50.50	2,637	133,168		Sep 17 11:15 AM
Carroll Patrick Harrison	Officer	Sep 17 '25	Proposed Sale	50.50	10,021	506,060		Sep 17 10:20 AM
Chi Michael	Officer	Sep 17 '25	Proposed Sale	50.50	13,749	694,324		Sep 17 10:07 AM
Becklund Irene	Officer	Sep 17 '25	Proposed Sale	50.50	8,410	424,705		Sep 17 09:50 AM
Dudum Andrew	Officer	Sep 16 '25	Proposed Sale	53.42	175,661	9,384,626		Sep 16 11:29 AM
Oluyemi Okupe	Officer	Sep 15 '25	Proposed Sale	53.96	145,000	7,824,200		Sep 15 06:35 PM
Chi Michael	Officer	Sep 15 '25	Proposed Sale	56.00	4,150	232,400		Sep 15 11:49 AM
Okupe Oluyemi	Chief Financial Officer	Aug 26 '25	Option Exercise	5.01	11,581	58,021	128,387	Aug 28 04:34 PM
Okupe Oluyemi	Chief Financial Officer	Aug 26 '25	Sale	43.69	11,581	505,968	116,806	Aug 28 04:34 PM
Boughton Soleil	Chief Legal Officer	Aug 25 '25	Sale	44.53	2,571	114,487	150,450	Aug 26 04:35 PM
Boughton Soleil	Officer	Aug 25 '25	Proposed Sale	44.53	2,571	114,487		Aug 25 09:46 AM
Dudum Andrew	Chief Executive Officer	Aug 18 '25	Option Exercise	2.43	125,335	304,564	197,855	Aug 20 04:14 PM
Dudum Andrew	Chief Executive Officer	Aug 18 '25	Sale	45.06	128,127	5,773,242	89,521	Aug 20 04:14 PM
Dudum Andrew	Chief Executive Officer	Aug 18 '25	Sale	45.05	47,534	2,141,492	142,592	Aug 20 04:14 PM
Dudum Andrew	Officer	Aug 18 '25	Proposed Sale	45.05	47,534	2,141,494		Aug 18 12:33 PM
Dudum Andrew	Officer	Aug 18 '25	Proposed Sale	45.22	128,127	5,793,903		Aug 18 10:22 AM
Okupe Oluyemi	Chief Financial Officer	Aug 13 '25	Option Exercise	5.01	11,581	58,021	65,665	Aug 15 04:18 PM
Okupe Oluyemi	Chief Financial Officer	Aug 13 '25	Sale	48.05	11,581	556,420	116,806	Aug 15 04:18 PM
Melissa Baird	Officer	Aug 12 '25	Proposed Sale	47.96	33,333	1,598,651		Aug 12 05:22 PM
Boughton Soleil	Chief Legal Officer	Aug 11 '25	Sale	51.64	2,572	132,818	153,021	Aug 12 04:33 PM
Dudum Andrew	Chief Executive Officer	Aug 07 '25	Sale	50.58	660,000	33,384,120	2,214,769	Aug 11 05:07 PM
Boughton Soleil	Officer	Aug 11 '25	Proposed Sale	51.64	2,572	132,818		Aug 11 10:18 AM
Carroll Patrick Harrison	Chief Medical Officer	Aug 06 '25	Sale	53.58	60,000	3,214,878	169,940	Aug 08 04:19 PM
Carroll Patrick Harrison	Officer	Aug 06 '25	Proposed Sale	53.58	60,000	3,214,881		Aug 06 01:27 PM
Chi Michael	Chief Commercial Officer	Jul 31 '25	Option Exercise	7.09	26,350	186,830	305,004	Aug 04 04:21 PM

Open in Screener

TDOC

Teladoc Health Inc

Apr 09 • 11:10AM ET

5.16

-0.11 -2.05 %

Healthcare • Health Information Services • USA • NYSE

TDOC Teladoc Health Inc daily Stock Chart

Peers: AMWL DOCS TVRD HIMS GDRX CLOV OSCR ACHC MD RMTI

| Held by: VTI IWM VB AVUV VBK VXF IWN FNDA VTWO SCHA

Index	RUT	P/E	-	EPS (ttm)	-1.14	Insider Own	2.20%	Shs Outstand	178.32M	Perf Week	-2.23%
Market Cap	920.92M	Forward P/E	-	EPS next Y	-0.74	Insider Trans	-3.94%	Shs Float	174.48M	Perf Month	-7.32%
Enterprise Value	1.18B	PEG	-	EPS next Q	-0.34	Inst Own	73.93%	Short Float	18.33%	Perf Quarter	-31.81%
Income	-200.32M	P/S	0.36	EPS this Y	21.39%	Inst Trans	5.16%	Short Ratio	5.09	Perf Half Y	-38.32%
Sales	2.53B	P/B	0.66	EPS next Y	17.92%	ROA	-5.84%	Short Interest	31.98M	Perf YTD	-26.25%
Book/sh	7.77	P/C	1.18	EPS next 5Y	14.33%	ROE	-13.93%	52W High	9.77 -47.16%	Perf Year	-34.49%
Cash/sh	4.38	P/FCF	3.27	EPS past 3/5Y	76.23% 26.67%	ROIC	-8.30%	52W Low	4.40 17.32%	Perf 3Y	-80.13%
Dividend Est.	-	EV/EBITDA	5.54	Sales past 3/5Y	1.68% 18.26%	Gross Margin	55.11%	Volatility	5.64% 4.83%	Perf 5Y	-97.15%
Dividend TTM	-	EV/Sales	0.47	EPS Y/Y TTM	80.61%	Oper. Margin	-6.46%	ATR (14)	0.26	Perf 10Y	-50.93%
Dividend Ex-Date	-	Quick Ratio	2.59	Sales Y/Y TTM	-1.54%	Profit Margin	-7.92%	RSI (14)	44.84	Recom	2.48
Dividend Gr. 3/5Y	- -	Current Ratio	2.69	EPS Q/Q	49.54%	SMA20	-3.84%	Beta	2.10	Target Price	7.00
Payout	-	Debt/Eq	0.75	Sales Q/Q	0.28%	SMA50	-0.01%	Rel Volume	0.72	Prev Close	5.27
Employees	5600	LT Debt/Eq	0.74	Earnings	Feb 25 AMC	SMA200	-27.05%	Avg Volume	6.29M	Price	5.16
IPO	Jul 01, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	22.78% 1.10%	Trades		Volume	1,322,592	Change	-2.05%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-10-26	Upgrade	Deutsche Bank	Hold → Buy	$11
Feb-26-26	Upgrade	BofA Securities	Neutral → Buy	$7
Dec-09-25	Initiated	Barclays	Equal Weight	$8.50
Nov-13-25	Initiated	BMO Capital Markets	Market Perform	$8
Jul-25-25	Initiated	Mizuho	Neutral	$10
Nov-15-24	Initiated	Goldman	Buy	$14
Sep-17-24	Reiterated	Jefferies	Hold	$8 → $10
Feb-29-24	Initiated	Cantor Fitzgerald	Overweight	$22
Feb-26-24	Initiated	Leerink Partners	Market Perform	$17
Jan-17-24	Downgrade	DA Davidson	Buy → Neutral	$33 → $22
Jan-03-24	Initiated	Barclays	Overweight	$26
Apr-12-23	Initiated	Stephens	Equal-Weight	$25
Feb-23-23	Upgrade	SVB Securities	Market Perform → Outperform	$34
Oct-24-22	Upgrade	Guggenheim	Sell → Neutral
Sep-16-22	Initiated	KeyBanc Capital Markets	Sector Weight
Sep-07-22	Initiated	Truist	Hold	$35
Aug-17-22	Downgrade	Guggenheim	Neutral → Sell	$25
Aug-12-22	Initiated	DA Davidson	Buy	$45
Aug-02-22	Downgrade	Cowen	Outperform → Market Perform	$58 → $34
Aug-02-22	Downgrade	Berenberg	Buy → Hold	$35

Show Previous Ratings

Apr-01-26 09:46AM	Disney upgraded, Nike downgraded: Wall Street's top analyst calls (The Fly)
Mar-30-26 04:30PM	Teladoc Health Appoints Susan Salka, Experienced Healthcare Executive, to Its Board of Directors (GlobeNewswire) +6.03%
Mar-11-26 06:00AM	Teladoc (TDOC) Surges 5.1%: Is This an Indication of Further Gains? (Zacks)
Mar-10-26 03:36PM	Why Teladoc (TDOC) Stock Is Up Today (StockStory) +5.09%
10:49AM	Teladoc Health Stock Pops - Here's Why (Benzinga)
10:09AM	Loading…
10:09AM	Wall Street Turns Bullish on HIMS, TDOC and ALEC as Partnerships Reshape Risk Profiles (24/7 Wall St.)
Mar-05-26 09:35AM	Hims and Hers Expands Its Technology Driven Consumer Health Platform (Zacks)
Mar-04-26 04:05PM	Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08 (GlobeNewswire)
Mar-03-26 04:05PM	Teladoc Health to Participate in Upcoming Investor Conference (GlobeNewswire)
Feb-28-26 10:06PM	Teladoc Health Q4 Earnings Call Highlights (MarketBeat)
Feb-26-26 12:39PM	Teladoc Tops Q4 Earnings Estimates on International Growth & Lower Costs (Zacks) +15.05%
12:18PM	What's Driving Teladoc Health's Rally? (Benzinga)
12:11PM	Why Teladoc (TDOC) Stock Is Up Today (StockStory)
09:30AM	Here's What Key Metrics Tell Us About Teladoc (TDOC) Q4 Earnings (Zacks)
07:03AM	Teladoc projects lower integrated care membership amid ACA subsidy lapse (Healthcare Dive)
12:02AM	Loading…
12:02AM	Teladoc Health Inc (TDOC) Q4 2025 Earnings Call Highlights: Navigating Challenges and Opportunities (GuruFocus.com)
Feb-25-26 05:03PM	Teladoc (NYSE:TDOC) Surprises With Q4 CY2025 Sales (StockStory)
04:05PM	Teladoc Health Reports Fourth Quarter and Full Year 2025 Results (GlobeNewswire)
Feb-23-26 10:05PM	Teladoc (TDOC) Q4 Earnings: What To Expect (StockStory)
10:33AM	Nvidia, Joby, CoreWeave, Lucid and More Stocks with Earnings This Week (Benzinga)
09:58AM	BofA and Goldman Cut Teladoc (TDOC) Price Targets (Insider Monkey)
09:15AM	Stay Ahead of the Game With Teladoc (TDOC) Q4 Earnings: Wall Street's Insights on Key Metrics (Zacks)
Feb-19-26 11:43PM	3 Unprofitable Stocks with Questionable Fundamentals (StockStory)
11:27AM	Teladoc Q4 Earnings: Can Integrated Care Strength Save Profits? (Zacks)
09:40AM	Is Teladoc Health (TDOC) Stock Undervalued Right Now? (Zacks)
Feb-18-26 07:44PM	BofA Lowers Teladoc (TDOC) PT on Peer Multiple Compression, Soft Sensor Tower Trends (Insider Monkey)
04:30PM	Teladoc Health Appoints Michael Smith, Experienced Insurance and Financial Services Executive, to Its Board of Directors (GlobeNewswire)
Feb-17-26 06:15PM	Teladoc (TDOC) Stock Slides as Market Rises: Facts to Know Before You Trade (Zacks)
Feb-12-26 09:59AM	Hims & Hers Strengthens Integrated Personalized Digital Care Platform (Zacks)
Feb-11-26 11:56AM	Telehealth stocks pressured as Amazon Pharmacy expands prescription delivery (Investing.com)
11:13AM	Loading…
11:13AM	HIMS Dips 55.8% in 3 Months: Should You Still Hold the Stock or Sell? (Zacks)
Feb-10-26 06:15PM	Teladoc (TDOC) Registers a Bigger Fall Than the Market: Important Facts to Note (Zacks)
Feb-05-26 04:30PM	Teladoc Health to Announce Fourth Quarter 2025 Financial Results (GlobeNewswire) +5.92%
Feb-04-26 02:36PM	Jim Cramer on Teladoc: "I Don't See Any Reason to Own It" (Insider Monkey)
Feb-02-26 06:15PM	Teladoc (TDOC) Stock Sinks As Market Gains: What You Should Know (Zacks)
Jan-29-26 04:50AM	Chuck Divita on why 2026 is Teladocs execution year (Healthcare Dive)
Jan-28-26 04:30PM	Once Medicare Stops Covering Telehealth Services, Will Teladoc Health Stock be in Trouble? (Motley Fool)
07:10AM	Danaher (DHR) Beats Q4 Earnings and Revenue Estimates (Zacks)
Jan-27-26 06:15PM	Teladoc (TDOC) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks) -6.04%
03:10PM	Why Teladoc (TDOC) Shares Are Plunging Today (StockStory)
10:20AM	Are Telehealth Stocks Set to Tumble in 2026? (Motley Fool)
08:55AM	How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings (Zacks)
Jan-21-26 10:50PM	2 Beaten-Down Stocks That Could Sink Even More in 2026 (Motley Fool)
08:55AM	These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar (Zacks)
Jan-20-26 11:04PM	3 Reasons to Avoid TDOC and 1 Stock to Buy Instead (StockStory)
01:00PM	Teladoc and EverQuote Shares Plummet, What You Need To Know (StockStory)
Jan-19-26 12:13PM	Hims & Hers Expands Platform-Led Access to Digital Healthcare (Zacks)
Jan-13-26 06:15PM	Teladoc (TDOC) Registers a Bigger Fall Than the Market: Important Facts to Note (Zacks) -5.44%
Jan-12-26 06:00AM	Teladoc Health Launches Enhanced 24/7 Care Service (GlobeNewswire)
Jan-08-26 11:34PM	3 Value Stocks with Open Questions (StockStory)
09:54AM	Hims & Hers Plunges 39.2% in 3 Months: Time to Hold the Stock or Sell? (Zacks)
Jan-07-26 06:15PM	Why Teladoc (TDOC) Dipped More Than Broader Market Today (Zacks) -5.37%
Jan-05-26 04:30PM	Teladoc Health to Participate in Upcoming Investor Conference (GlobeNewswire) +9.89%
Jan-04-26 11:23AM	3 Reasons to Forget Teladoc Health Stock (Motley Fool)
Dec-30-25 12:41PM	HIMS Scales AI-Enabled Care as Platform Depth and Engagement Expand (Zacks)
Dec-29-25 11:35PM	3 Volatile Stocks That Concern Us (StockStory)
Dec-27-25 01:01PM	Down 98% From Its All-Time High? Is It Finally Time to Buy This Former Market Darling? (Motley Fool)
Dec-24-25 12:22PM	HIMS vs. TDOC: Which Telehealth Stock Looks More Compelling? (Zacks)
Dec-22-25 11:55AM	Why Teladoc (TDOC) Stock Is Up Today (StockStory)
09:53AM	Barclays Initiates Coverage on Teladoc (TDOC) with Equal Weight at $8.50 (Insider Monkey)
Dec-13-25 11:35AM	Private Markets: Musks SpaceX targets 2026 IPO at valuation of $1.5T (TipRanks)
07:13AM	Forget Teladoc and Buy This Healthcare Stock Instead (Motley Fool)
Dec-11-25 10:32AM	Hims & Hers Expands Its Technology-Driven Personalized Virtual Care (Zacks)
Dec-09-25 11:25AM	Hims & Hers Plunges 29.1% in 6 Months: Time to Hold the Stock or Sell? (Zacks)
Dec-01-25 05:57AM	3 Unprofitable Stocks We Approach with Caution (StockStory)
Nov-28-25 11:30AM	Why Is Teladoc (TDOC) Down 14.8% Since Last Earnings Report? (Zacks)
Nov-26-25 04:05PM	Teladoc Health to Participate in Upcoming Investor Conference (GlobeNewswire)
Nov-24-25 04:55PM	Teladoc, Angi, Upwork, and ACV Auctions Shares Are Soaring, What You Need To Know (StockStory)
Nov-21-25 11:06AM	Does Teladoc's Acquisition Strategy Boost Growth and Global Footprint? (Zacks)
Nov-20-25 04:55PM	Teladoc and Netflix Shares Are Falling, What You Need To Know (StockStory)
11:42AM	TDOC vs. LFMD: Which Telehealth Stock Is Better for Your Portfolio? (Zacks)
Nov-19-25 10:32PM	Online Marketplace Stocks Q3 Highlights: Teladoc (NYSE:TDOC) (StockStory)
12:24PM	TDOC Partners With TytoCare to Expand At-Home Exam Capabilities (Zacks)
Nov-18-25 11:43AM	Hims & Hers Plunges 15.6% in 3 Months: Time to Hold the Stock or Sell? (Zacks)
09:00AM	TytoCare Integrates With Teladoc Health to Augment Virtual Primary and Urgent Care (PR Newswire)
Nov-17-25 11:23AM	Is Teladoc Health Accelerating Growth Through Global Expansion? (Zacks)
Nov-15-25 11:42PM	Teladoc Health Held In-Line Rating in Late Ocotber as Evercore Reversed Price Target Back to $8 (Insider Monkey)
Nov-13-25 03:55PM	Teladoc, MercadoLibre, Reddit, Lyft, and Wayfair Stocks Trade Down, What You Need To Know (StockStory) -5.35%
Nov-11-25 01:26PM	Teladoc Health's Q3 Loss Widens Y/Y on Weak BetterHelp Unit (Zacks)
12:43PM	Hims & Hers Scales Technology-Enabled, Vertically Integrated Care (Zacks)
Nov-10-25 12:47PM	How is Teladoc Health Placed in the Growing Telemedicine Market? (Zacks)
Nov-06-25 04:30PM	Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08 (GlobeNewswire) -5.46%
01:31PM	1 Russell 2000 Stock to Keep an Eye On and 2 Facing Challenges (StockStory)
Nov-05-25 12:23PM	How to Play Teladoc Health Stock Post Q3 Results: Buy, Hold or Sell? (Zacks)
06:45AM	Why Teladoc Stock Zoomed Almost 12% Higher in October (Motley Fool)
12:32AM	The 5 Most Interesting Analyst Questions From Teladoc's Q3 Earnings Call (StockStory)
Nov-04-25 11:42AM	Sovato raises Series B funds to advance remote robotic surgery platform (Medical Device Network)
Nov-03-25 09:24PM	Is This Beaten-Down Stock Finally on the Road to Recovery? (Motley Fool) -5.68%
04:01PM	Why Teladoc (TDOC) Shares Are Getting Obliterated Today (StockStory)
Oct-31-25 07:38AM	Harry Yous Berto Embraces Clinic-in-a-Box with OnMed Event Flash (Exec Edge)
Oct-30-25 06:54PM	Teladoc Finds Its Groove With Strong Q3, AI Push (GuruFocus.com) +6.20%
04:11PM	Teladoc Health Inc (TDOC) Q3 2025 Earnings Call Highlights: Navigating Challenges and Seizing ... (GuruFocus.com)
02:35PM	Why Teladoc (TDOC) Stock Is Trading Up Today (StockStory)
09:16AM	TDOC Q3 CY2025 Deep Dive: Insurance Pivot, International Growth, and Margin Pressures (StockStory)
09:00AM	Teladoc expands insurance coverage at mental health unit BetterHelp (Healthcare Dive)
Oct-29-25 07:00PM	Teladoc (TDOC) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks)
05:45PM	Teladoc (TDOC) Reports Q3 Loss, Beats Revenue Estimates (Zacks)
04:45PM	Teladoc: Q3 Earnings Snapshot (Associated Press Finance)
04:27PM	Teladoc's (NYSE:TDOC) Q3 Earnings Results: Revenue In Line With Expectations (StockStory)
04:05PM	Teladoc Health Reports Third Quarter 2025 Results (GlobeNewswire)

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Catapano Joseph Ronald	Chief Accounting Officer	Apr 02 '26	Sale	5.11	675	3,452	10,249	Apr 03 03:58 PM
DIVITA CHARLES III	CHIEF EXECUTIVE OFFICER	Mar 11 '26	Sale	5.49	27,731	152,243	364,784	Mar 12 04:06 PM
DIVITA CHARLES III	Officer	Mar 11 '26	Proposed Sale	5.49	27,731	152,252		Mar 11 03:35 PM
Vandervoort Adam C	CHIEF LEGAL OFFICER, SECRETARY	Mar 02 '26	Sale	5.12	27,083	138,584	103,239	Mar 03 04:11 PM
DIVITA CHARLES III	CHIEF EXECUTIVE OFFICER	Mar 02 '26	Sale	5.12	50,145	256,592	327,862	Mar 03 04:09 PM
Bliss Kelly	President, U.S. Group Health	Mar 02 '26	Sale	5.12	26,647	136,353	84,747	Mar 03 04:08 PM
Rodrigues Fernando M.	Officer	Mar 03 '26	Proposed Sale	4.98	25,086	124,973		Mar 03 11:18 AM
Rodrigues Fernando M.	Officer	Mar 02 '26	Proposed Sale	5.12	16,314	83,474		Mar 02 05:12 PM
DIVITA CHARLES III	Officer	Mar 02 '26	Proposed Sale	5.12	50,145	256,577		Mar 02 05:10 PM
Bliss Kelly	Officer	Mar 02 '26	Proposed Sale	5.12	26,647	136,345		Mar 02 04:59 PM
Vandervoort Adam C	Officer	Mar 02 '26	Proposed Sale	5.12	27,083	138,576		Mar 02 04:57 PM
Nueno Carlos	Officer	Mar 02 '26	Proposed Sale	5.12	20,165	103,178		Mar 02 04:49 PM
Catapano Joseph Ronald	Chief Accounting Officer	Jan 05 '26	Sale	7.14	758	5,416	6,686	Jan 06 04:05 PM
DIVITA CHARLES III	CHIEF EXECUTIVE OFFICER	Dec 11 '25	Sale	7.63	17,138	130,837	201,036	Dec 11 04:23 PM
DIVITA CHARLES III	Officer	Dec 11 '25	Proposed Sale	7.63	17,138	130,837		Dec 11 03:46 PM
Rodrigues Fernando M.	President of BetterHelp	Dec 03 '25	Sale	7.48	4,209	31,483	0	Dec 03 09:04 PM
Rodrigues Fernando M.	President of BetterHelp	Dec 02 '25	Sale	7.49	2,324	17,402	4,209	Dec 03 09:04 PM
Vandervoort Adam C	CHIEF LEGAL OFFICER, SECRETARY	Dec 02 '25	Sale	7.49	5,720	42,831	80,732	Dec 03 09:04 PM
Nueno Carlos	President, International	Dec 02 '25	Sale	7.49	3,897	29,181	27,175	Dec 03 09:03 PM
Bliss Kelly	President, U.S. Group Health	Dec 02 '25	Sale	7.49	4,582	34,310	60,054	Dec 03 09:03 PM
Rodrigues Fernando M.	Officer	Dec 03 '25	Proposed Sale	7.48	4,209	31,483		Dec 03 09:46 AM
Vandervoort Adam C	Officer	Dec 02 '25	Proposed Sale	7.49	5,720	42,833		Dec 02 04:25 PM
Nueno Carlos	Officer	Dec 02 '25	Proposed Sale	7.49	3,897	29,182		Dec 02 04:22 PM
Bliss Kelly	Officer	Dec 02 '25	Proposed Sale	7.49	4,582	34,311		Dec 02 04:15 PM
Rodrigues Fernando M.	Officer	Dec 02 '25	Proposed Sale	7.49	2,324	17,403		Dec 02 04:14 PM
Paulus Kenneth H	Director	Nov 14 '25	Buy	6.94	10,000	69,400	10,000	Nov 17 04:05 PM
Catapano Joseph Ronald	Chief Accounting Officer	Oct 02 '25	Sale	7.88	2,972	23,434	5,361	Oct 03 04:05 PM
DIVITA CHARLES III	CHIEF EXECUTIVE OFFICER	Sep 11 '25	Sale	7.59	16,787	127,435	179,014	Sep 11 04:04 PM
DIVITA CHARLES III	Officer	Sep 11 '25	Proposed Sale	7.59	16,787	127,435		Sep 11 03:28 PM
Rodrigues Fernando M.	President of BetterHelp	Sep 03 '25	Sale	7.59	4,149	31,491	0	Sep 03 04:05 PM
Rodrigues Fernando M.	President of BetterHelp	Sep 02 '25	Sale	7.58	2,383	18,075	4,149	Sep 03 04:05 PM
Nueno Carlos	President, International	Sep 02 '25	Sale	7.58	3,998	30,325	22,359	Sep 03 04:05 PM
Vandervoort Adam C	CHIEF LEGAL OFFICER, SECRETARY	Sep 02 '25	Sale	7.58	5,867	44,501	75,179	Sep 03 04:05 PM
Bliss Kelly	President, U.S. Group Health	Sep 02 '25	Sale	7.58	4,700	35,650	55,101	Sep 03 04:05 PM
Murthy Mala	CHIEF FINANCIAL OFFICER	Sep 02 '25	Sale	7.58	12,846	97,437	142,385	Sep 03 04:05 PM
Rodrigues Fernando M.	Officer	Sep 03 '25	Proposed Sale	7.59	4,149	31,491		Sep 03 11:45 AM
Rodrigues Fernando M.	Officer	Sep 02 '25	Proposed Sale	7.59	2,383	18,076		Sep 02 04:33 PM
Bliss Kelly	Officer	Sep 02 '25	Proposed Sale	7.59	4,700	35,651		Sep 02 04:15 PM
Nueno Carlos	Officer	Sep 02 '25	Proposed Sale	7.59	3,998	30,326		Sep 02 04:09 PM
Vandervoort Adam C	Officer	Sep 02 '25	Proposed Sale	7.59	5,867	44,503		Sep 02 04:05 PM
Murthy Mala	Officer	Sep 02 '25	Proposed Sale	7.59	12,846	97,441		Sep 02 03:59 PM
Rodrigues Fernando M.	President of BetterHelp	Jun 03 '25	Sale	6.91	4,174	28,842	0	Jun 03 05:37 PM
Rodrigues Fernando M.	President of BetterHelp	Jun 02 '25	Sale	6.86	2,358	16,176	4,174	Jun 03 05:37 PM
Vandervoort Adam C	CHIEF LEGAL OFFICER, SECRETARY	Jun 02 '25	Sale	6.86	5,808	39,843	69,773	Jun 03 05:37 PM
Bliss Kelly	President, U.S. Group Health	Jun 02 '25	Sale	6.86	4,653	31,920	50,266	Jun 03 05:36 PM
Murthy Mala	CHIEF FINANCIAL OFFICER	Jun 02 '25	Sale	6.86	13,856	95,052	132,443	Jun 03 05:36 PM
Nueno Carlos	President, International	Jun 02 '25	Sale	6.86	3,958	27,152	17,645	Jun 03 05:36 PM
Rodrigues Fernando M.	Officer	Jun 03 '25	Proposed Sale	6.91	4,174	28,842		Jun 03 10:53 AM
Murthy Mala	Officer	Jun 02 '25	Proposed Sale	6.86	13,856	95,052		Jun 02 03:46 PM
Rodrigues Fernando M.	Officer	Jun 02 '25	Proposed Sale	6.86	2,358	16,176		Jun 02 03:45 PM
Vandervoort Adam C	Officer	Jun 02 '25	Proposed Sale	6.86	5,808	39,843		Jun 02 03:44 PM
Bliss Kelly	Officer	Jun 02 '25	Proposed Sale	6.86	4,653	31,920		Jun 02 03:43 PM
Nueno Carlos	Officer	Jun 02 '25	Proposed Sale	6.86	3,958	27,152		Jun 02 03:38 PM

Open in Screener

TOI

Oncology Institute Inc

Apr 09 • 11:10AM ET

3.06

-0.04 -1.29 %

Healthcare • Medical Care Facilities • USA • NASD

TOI Oncology Institute Inc daily Stock Chart

Peers: AMGN BMY PFE MRK LLY AZN-D GILD REGN VRTX BIIB

| Held by: VTI IWM VXF IWO VFMO VTWO IWC GSSC VTWG FESM

Index	RUT	P/E	-	EPS (ttm)	-0.56	Insider Own	34.43%	Shs Outstand	98.86M	Perf Week	-2.55%
Market Cap	302.45M	Forward P/E	-	EPS next Y	-0.08	Insider Trans	1.68%	Shs Float	64.81M	Perf Month	17.24%
Enterprise Value	372.64M	PEG	-	EPS next Q	-0.08	Inst Own	35.72%	Short Float	13.86%	Perf Quarter	-24.82%
Income	-50.26M	P/S	0.60	EPS this Y	57.87%	Inst Trans	7.01%	Short Ratio	4.52	Perf Half Y	-19.90%
Sales	502.73M	P/B	-	EPS next Y	64.84%	ROA	-28.37%	Short Interest	8.98M	Perf YTD	-14.04%
Book/sh	-0.16	P/C	9.01	EPS next 5Y	-	ROE	-3407.86%	52W High	4.88 -37.30%	Perf Year	94.90%
Cash/sh	0.34	P/FCF	-	EPS past 3/5Y	-37.23% -17.58%	ROIC	-62.18%	52W Low	1.35 126.67%	Perf 3Y	343.54%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	25.81% 21.80%	Gross Margin	13.82%	Volatility	6.97% 9.95%	Perf 5Y	-69.64%
Dividend TTM	-	EV/Sales	0.74	EPS Y/Y TTM	20.34%	Oper. Margin	-7.18%	ATR (14)	0.26	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.35	Sales Y/Y TTM	27.79%	Profit Margin	-10.00%	RSI (14)	49.73	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.59	EPS Q/Q	55.70%	SMA20	-3.15%	Beta	0.20	Target Price	7.00
Payout	-	Debt/Eq	-	Sales Q/Q	41.58%	SMA50	6.10%	Rel Volume	0.60	Prev Close	3.10
Employees	641	LT Debt/Eq	-	Earnings	Mar 12 AMC	SMA200	-9.13%	Avg Volume	1.99M	Price	3.06
IPO	Jun 04, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	33.33% 1.55%	Trades		Volume	352,118	Change	-1.29%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-25-25	Initiated	Needham	Buy	$5
Jul-23-25	Initiated	Noble Capital Markets	Outperform	$8
Jul-16-25	Initiated	B. Riley Securities	Buy	$6
May-15-25	Initiated	BTIG Research	Buy	$7
Feb-26-24	Resumed	Jefferies	Buy	$2.50
Sep-14-22	Initiated	Guggenheim	Buy	$7
Aug-15-22	Initiated	Jefferies	Buy	$10

Today 09:00AM	The Oncology Institute to Participate in the 25th Annual Needham Healthcare Conference (GlobeNewswire)
Apr-06-26 09:00AM	The Oncology Institute Names Minh Merchant Chief Legal Officer (GlobeNewswire)
Mar-13-26 08:30AM	The Oncology Institute, Inc. Q4 2025 Earnings Call Summary (Moby) +8.40%
Mar-12-26 11:03PM	The Oncology Institute Inc (TOI) Q4 2025 Earnings Call Highlights: Record Revenue and First ... (GuruFocus.com) -5.07%
04:05PM	The Oncology Institute Reports Fourth Quarter and Full Year 2025 Financial Results and Guidance for 2026 (GlobeNewswire)
09:27AM	Loading…
Mar-11-26 09:27AM	The Oncology Institute Inc (TOI) Q4 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com) +5.75%
Feb-26-26 06:00PM	Alignment Healthcare (ALHC) Reports Q4 Loss, Beats Revenue Estimates (Zacks)
08:00AM	The Oncology Institute Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Conference Call (GlobeNewswire)
Feb-25-26 08:00AM	The Oncology Institute to Participate in Multiple Healthcare Investor Conferences in March (GlobeNewswire) +10.85%
Feb-23-26 08:00AM	The Oncology Institute Appoints Kim Tzoumakas to Board of Directors (GlobeNewswire)
Jan-12-26 08:00AM	The Oncology Institute Reaffirms 2025 Guidance and Provides Preliminary 2026 Outlook (GlobeNewswire) -7.89%
Jan-09-26 08:00AM	The Oncology Institute Announces Leadership Promotions (GlobeNewswire)
Jan-05-26 08:30AM	The Oncology Institute Announces Addition of Board Member Mark Stolper (GlobeNewswire) +6.81%
Dec-01-25 08:30AM	The Oncology Institute Announces Resignation of Board Member Gabe Ling (GlobeNewswire) -6.37%
Nov-21-25 05:20AM	A Mysterious Stock Has Rallied Over 950% This Year. Here's 1 Key Reason Why Investors Are Turning Bullish (Motley Fool)
12:06AM	Loading…
Nov-14-25 12:06AM	The Oncology Institute Inc (TOI) Q3 2025 Earnings Call Highlights: Revenue Surge and AI ... (GuruFocus.com) +28.90%
Nov-13-25 05:30PM	The Oncology Institute, Inc. (TOI) Reports Q3 Loss, Beats Revenue Estimates (Zacks) -10.20%
04:05PM	The Oncology Institute Reports Third Quarter 2025 Financial Results and Increases Full Year 2025 Guidance (GlobeNewswire)
04:04PM	Ascertain and The Oncology Institute Co-Develop 'Touchless' AI Automation for Oncology Administration (GlobeNewswire)
Nov-12-25 06:25PM	Biorestorative Therapies, Inc. (BRTX) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
07:26AM	Earnings To Watch: The Oncology Institute Inc (TOI) Reports Q3 2025 Result (GuruFocus.com)
Nov-05-25 09:15AM	Establishment Labs Holdings Inc. (ESTA) Reports Q3 Loss, Beats Revenue Estimates (Zacks)
Nov-04-25 05:50PM	CryoPort, Inc. (CYRX) Reports Q3 Loss, Tops Revenue Estimates (Zacks) -5.57%
Oct-29-25 07:15AM	Avantor, Inc. (AVTR) Q3 Earnings and Revenues Miss Estimates (Zacks)
Oct-22-25 04:47PM	The Oncology Institute Announces Third Quarter 2025 Earnings Release Date and Conference Call (GlobeNewswire) +5.01%
Oct-21-25 09:45AM	This Healthcare Stock Is Up 1,000%, Outpacing Nvidia, Tesla, and Apple Combined (Motley Fool)
Oct-01-25 08:00AM	The Oncology Institute to Participate in the Noble Capital Markets Emerging Growth Virtual Equity Conference (GlobeNewswire)
Sep-29-25 08:00AM	The Oncology Institute Partners with Protocol Behavioral Health to Integrate Mental Health Services into Cancer Care (GlobeNewswire)
Sep-22-25 08:00AM	The Oncology Institute Achieves $1.1 Million in Medicare Savings in CMS Enhancing Oncology Model Performance Period 2 through its California Professional Corporation (GlobeNewswire) +9.62%
Sep-18-25 09:35AM	The Oncology Institute (TOI) Loses 20% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks) +8.36%
04:05PM	Loading…
Sep-02-25 04:05PM	The Oncology Institute Launches Lung Cancer Center of Excellence in Florida Led by International Oncology Expert Dr. Edgardo Santos (GlobeNewswire)
Aug-18-25 08:00AM	The Oncology Institute and Doctors Healthcare Plans Partner to Elevate Oncology Care Management in South Florida (GlobeNewswire) +7.45%
Aug-14-25 03:14AM	The Oncology Institute Inc (TOI) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com) -10.49%
Aug-13-25 04:05PM	The Oncology Institute Reports Second Quarter 2025 Financial Results and Reaffirms Full Year 2025 Guidance (GlobeNewswire)
04:04PM	The Oncology Institute Announces Changes to Board of Directors (GlobeNewswire)
Jul-24-25 04:05PM	The Oncology Institute Announces Second Quarter 2025 Earnings Release Date and Conference Call (GlobeNewswire)
Jul-14-25 04:05PM	The Oncology Institute Names Kristin England as Chief Administrative Officer (GlobeNewswire) -7.48%
Jul-09-25 07:20AM	The Oncology Institute Becomes Exclusive Oncology Provider for 80,000+ SilverSummit Healthplan Medicaid Members (Insider Monkey)
Jun-30-25 04:05PM	The Oncology Institute and SilverSummit Healthplan Partner to Provide Oncology Care to Over 80,000 Medicaid Members in Nevada (GlobeNewswire) -6.39% +7.32%
Jun-03-25 08:00AM	The Oncology Institute set to join the Russell 2000 and Russell 3000 Indexes (GlobeNewswire)
May-14-25 04:06PM	The Oncology Institute Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 Guidance (GlobeNewswire) -10.57% +28.27%
04:05PM	The Oncology Institute Welcomes Dr. Jeff Langsam as Chief Clinical Officer (GlobeNewswire)
May-13-25 07:08PM	Topicus.com Inc. Announces Election of Members of the Board of Directors (GlobeNewswire)
04:05PM	The Oncology Institute to Participate at the B. Riley Securities 25th Annual Institutional Investor Conference (GlobeNewswire)
May-08-25 08:00AM	The Oncology Institute to Present at Upcoming ASCO Annual Meeting on High-Value Cancer Care Model Outcomes Showing Cost Savings and Lower Hospitalization Rates (GlobeNewswire) +6.18%
May-07-25 05:03PM	Constellation Software Inc. and Topicus.Com Inc. Announce Results for Topicus.com Inc. for the First Quarter Ended March 31, 2025 (GlobeNewswire) +5.36%
May-01-25 05:48PM	Topicus.com Inc. Defers Release Date for First Quarter Results (GlobeNewswire) +12.50%
Apr-30-25 06:04AM	Why The Oncology Institute, Inc. (TOI) is Surging in 2025 (Insider Monkey)
Apr-26-25 11:00AM	Microsoft, Apple Set To Report Earnings As Markets Watch Out For Core PCE Price Index (Seeking Alpha)
Apr-23-25 08:00AM	The Oncology Institute Announces First Quarter 2025 Earnings Release Date and Conference Call (GlobeNewswire) +6.27%
Apr-22-25 04:05PM	The Oncology Institute of Hope and Innovation Expands Research Partnership with Helios Clinical Across Markets, Enhancing Access to Cutting-Edge Cancer Trials (GlobeNewswire) +13.39%
Apr-01-25 10:04AM	The Oncology Institute, Inc. (TOI): Among Stocks Insiders Were Buying In Q1 2025 (Insider Monkey) +10.53%
Mar-31-25 08:00AM	TOI Launches Florida Oncology Network, a Fully Delegated Cancer Care Network, and Announces Four Additional Value-based Contracts in Q1 (GlobeNewswire)
Mar-26-25 03:02AM	The Oncology Institute Inc (TOI) Q4 2024 Earnings Call Highlights: Navigating Growth Amidst ... (GuruFocus.com)
Mar-25-25 06:28PM	The Oncology Institute, Inc. (TOI) Q4 2024 Earnings Call Transcript (SeekingAlpha)
Mar-24-25 09:05AM	Earnings To Watch: The Oncology Institute Inc (TOI) Reports Q4 2024 Result (GuruFocus.com) +24.47%
06:01AM	The Oncology Institute Reports Fourth Quarter and Full Year 2024 Financial Results and Guidance for 2025 (GlobeNewswire)
06:00AM	The Oncology Institute Announces $16.5 million Private Placement (GlobeNewswire)
Mar-04-25 08:00AM	The Oncology Institute Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Conference Call (GlobeNewswire)
Feb-26-25 08:00AM	The Oncology Institute Announces Amendment to Facility Agreement and Debt Paydown (GlobeNewswire) +19.66%
Dec-18-24 04:05PM	Florida Blue enhances cancer care for thousands of members (GlobeNewswire) +11.12%
Nov-13-24 04:05PM	The Oncology Institute Reports Third Quarter 2024 Financial Results (GlobeNewswire) -9.03% -10.84%
Nov-11-24 08:00AM	The Oncology Institute Announces Certification to Administer Pluvicto Therapy in California (GlobeNewswire)
Nov-04-24 07:09PM	The Oncology Institute Announces Third Quarter 2024 Earnings Release Date and Conference Call (GlobeNewswire) -6.64%
Oct-23-24 08:00AM	The Oncology Institute Joins Lantern's Cancer Care Network of Excellence (GlobeNewswire)
Oct-14-24 08:00AM	The American Journal of Managed Care and The Oncology Institute to Co-Host Symposium for Value-Based Cancer Care (GlobeNewswire)
Sep-30-24 08:00AM	The Oncology Institute of Hope & Innovation Launches Oregon Market (GlobeNewswire) +5.59%
Sep-23-24 08:00AM	The Oncology Institute Announces CFO Transition (GlobeNewswire)
Aug-13-24 04:05PM	The Oncology Institute Reports Second Quarter 2024 Financial Results and Updates Full Year 2024 Guidance (GlobeNewswire) +13.40% -18.18%
Jul-23-24 08:00AM	The Oncology Institute Announces Second Quarter 2024 Earnings Release Date and Conference Call (GlobeNewswire)
May-29-24 08:00AM	The Oncology Institute to Participate at Upcoming Investor Conferences (GlobeNewswire)
May-22-24 08:00AM	The Oncology Institute Executives to Participate in Multiple Panel Presentations at APG 2024 Spring Conference (GlobeNewswire)
May-15-24 03:14AM	The Oncology Institute Inc (TOI) (Q1 2024) Earnings Call Transcript Highlights: Navigating ... (GuruFocus.com) -24.00%
May-14-24 06:05PM	The Oncology Institute, Inc. (TOI) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
04:05PM	The Oncology Institute Reports First Quarter 2024 Financial Results and Reaffirms Full Year 2024 Guidance (GlobeNewswire)
May-07-24 04:05PM	The Oncology Institute to Participate in Panel Discussion at the Leerink Healthcare Transformation Summit (GlobeNewswire) -6.08%
Apr-23-24 08:00AM	The Oncology Institute Announces First Quarter 2024 Earnings Release Date and Conference Call (GlobeNewswire)
Apr-08-24 08:00AM	Jordan McInerney Appointed as Chief Development Officer of The Oncology Institute (GlobeNewswire) +6.00%
Apr-04-24 08:00AM	The Oncology Institute and Healthly Forge Strategic Alliance to Elevate Cancer Care Access to Healthly Patients Across Southern California (GlobeNewswire)
Apr-01-24 01:35PM	The Oncology Institute, Inc. (NASDAQ:TOI) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-27-24 08:52PM	TOI Stock Earnings: The Oncology Institute Misses EPS, Beats Revenue for Q4 2023 (InvestorPlace) +8.88% -14.13%
05:34PM	The Oncology Institute Inc (TOI) Reports Mixed Q4 and Full Year 2023 Results (GuruFocus.com)
04:05PM	The Oncology Institute Reports Fourth Quarter and Full Year 2023 Financial Results and Guidance for 2024 (GlobeNewswire)
Mar-21-24 09:35AM	Down -23.64% in 4 Weeks, Here's Why The Oncology Institute (TOI) Looks Ripe for a Turnaround (Zacks)
Mar-14-24 08:09AM	MaxHealth & The Oncology Institute Expand Value-Based Care Partnership (GlobeNewswire) +5.62%
Mar-06-24 08:00AM	The Oncology Institute Announces Fourth Quarter and Full Year 2023 Earnings Release Date and Conference Call (GlobeNewswire)
Feb-27-24 04:05PM	The Oncology Institute to Participate at Upcoming Investor Conferences (GlobeNewswire)
Feb-20-24 08:00AM	Carrum Health and The Oncology Institute Partner on Breast Cancer Treatment Model (GlobeNewswire)
Jan-25-24 08:00AM	WellBe Senior Medical Partners with The Oncology Institute to Extend High-Value Cancer Care Services Across Illinois and Ohio (GlobeNewswire)
Dec-04-23 08:00AM	The Oncology Institute Expands its Specialty Medication Business by Opening Pharmacy Operations in California (GlobeNewswire)
Nov-16-23 05:04AM	Insider Sell Alert: Director Brad Hively Sells 47,000 Shares of The Oncology Institute Inc (TOI) (GuruFocus.com) -7.21%
Nov-11-23 12:43PM	The Oncology Institute, Inc. (NASDAQ:TOI) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-08-23 05:50PM	The Oncology Institute Inc (TOI) Reports Q3 2023 Results: Revenue Up, Net Loss Widens (GuruFocus.com) +5.75% +27.72%
04:05PM	The Oncology Institute Reports Third Quarter 2023 Financial Results and Reaffirms Full Year 2023 Guidance (GlobeNewswire)
Oct-18-23 08:03AM	The Oncology Institute Announces Third Quarter 2023 Earnings Release Date and Conference Call (GlobeNewswire)
Oct-11-23 04:05PM	The Oncology Institute Names Jeremy Castle as Chief Operations Officer (GlobeNewswire)
Sep-26-23 04:05PM	The Oncology Institute Executive Leaders to Present at the 2023 Association for Value-Based Cancer Care (AVBCC) Summit (GlobeNewswire)
Sep-18-23 08:00AM	The Oncology Institute Regains Compliance with Nasdaq Listing Requirements (GlobeNewswire)
Aug-09-23 08:10AM	Ambience Healthcare and The Oncology Institute (TOI) Partner to Create a Best-in-Class Oncology Experience for Patients and Clinicians, Leveraging Breakthrough Generative AI Technology (GlobeNewswire)
Aug-08-23 04:40PM	The Oncology Institute Reports Second Quarter 2023 Financial Results and Reaffirms Full Year 2023 Guidance (GlobeNewswire)

The Oncology Institute, Inc. provides cancer care treatment services. It operates through the following business segments: Dispensary, Patient Care, and Clinical Trials and Other. The company was founded in 2007 and is headquartered in Cerritos, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Chernett Jorey	10% Owner	Mar 27 '26	Buy	2.96	27,429	81,190	10,479,358	Mar 30 09:38 AM
Chernett Jorey	10% Owner	Mar 26 '26	Buy	3.15	50,000	157,500	10,451,929	Mar 27 09:34 AM
Chernett Jorey	10% Owner	Mar 24 '26	Buy	3.11	125,000	388,750	10,401,929	Mar 25 09:33 AM
Chernett Jorey	10% Owner	Mar 20 '26	Buy	3.35	25,000	83,750	10,276,929	Mar 23 09:33 AM
Chernett Jorey	10% Owner	Mar 13 '26	Buy	2.92	263,000	767,960	10,115,944	Mar 17 07:40 PM
Chernett Jorey	10% Owner	Mar 17 '26	Buy	3.42	75,000	256,500	10,251,929	Mar 17 07:40 PM
Chernett Jorey	10% Owner	Mar 16 '26	Buy	3.29	60,985	200,641	10,176,929	Mar 17 07:40 PM
Carter Robert Ross	Chief Financial Officer	Jan 02 '26	Sale	3.56	247	879	235,122	Jan 05 05:04 PM
Hively Brad	Director	Dec 15 '25	Sale	3.77	13,333	50,291	683,721	Dec 16 04:30 PM
BRADFORD DANIEL HIVELY	Director	Dec 15 '25	Proposed Sale	3.77	13,333	50,291		Dec 15 04:07 PM
Pacala Mark L	Director	Nov 18 '25	Sale	4.00	50,000	200,000	174,971	Nov 20 04:55 PM
MARK PACALA	Director	Nov 18 '25	Proposed Sale	4.00	50,000	200,000		Nov 18 04:05 PM
M33 Growth I L.P.	Director	Sep 04 '25	Sale	3.09	6,018,168	18,596,139	7,932,389	Sep 05 06:12 AM
M33 Growth I L.P.	Director	Sep 04 '25	Sale	3.09	681,832	2,106,861	590,892	Sep 05 06:12 AM
Hively Brad	Director	Aug 19 '25	Sale	4.06	20,221	82,097	622,980	Aug 21 03:13 PM
M33 Growth I L.P.	Director	Jun 05 '25	Sale	3.05	673,676	2,054,712	13,950,557	Jun 09 04:15 PM
M33 Growth I L.P.	Director	Jun 05 '25	Sale	3.05	76,324	232,788	1,272,724	Jun 09 04:15 PM
Hively Brad	Director	Jun 03 '25	Option Exercise	0.90	1,867,605	1,682,524	2,579,638	Jun 05 06:51 PM
Hively Brad	Director	Jun 03 '25	Sale	2.87	1,976,137	5,672,106	603,501	Jun 05 06:51 PM
TOI M, LLC	10% Owner	Jun 05 '25	Proposed Sale	3.20	127,207	407,062		Jun 05 06:17 PM
M33 Growth I L.P.	10% Owner	Jun 05 '25	Proposed Sale	3.20	1,122,793	3,592,938		Jun 05 06:13 PM
BRADFORD DANIEL HIVELY	Director	Jun 03 '25	Proposed Sale	2.87	39,600	113,652		Jun 03 05:08 PM
BRADFORD DANIEL HIVELY	Director	Jun 03 '25	Proposed Sale	2.87	1,936,537	5,557,861		Jun 03 04:27 PM
M33 Growth I L.P.	Director	May 20 '25	Sale	2.71	1,796,468	4,873,638	14,624,233	May 22 07:38 PM
M33 Growth I L.P.	Director	May 20 '25	Sale	2.71	203,532	552,162	1,349,048	May 22 07:38 PM
TOI M, LLC	10% Owner	May 20 '25	Proposed Sale	3.06	203,532	622,808		May 20 06:25 PM
M33 Growth I L.P.	10% Owner	May 20 '25	Proposed Sale	3.06	1,796,468	5,497,192		May 20 06:19 PM

SBC SBC Medical Group Holdings Inc daily Stock Chart

Held by: IWM VXF IWN VTWO IWC VTWV RSSL URTY UWM FLQS

Index	RUT	P/E	8.37	EPS (ttm)	0.50	Insider Own	96.80%	Shs Outstand	102.58M	Perf Week	-5.80%
Market Cap	425.18M	Forward P/E	8.46	EPS next Y	0.49	Insider Trans	-4.26%	Shs Float	3.29M	Perf Month	10.53%
Enterprise Value	327.75M	PEG	-	EPS next Q	0.10	Inst Own	1.29%	Short Float	9.34%	Perf Quarter	-6.43%
Income	50.99M	P/S	2.45	EPS this Y	-9.20%	Inst Trans	3.42%	Short Ratio	9.61	Perf Half Y	0.61%
Sales	173.61M	P/B	1.71	EPS next Y	7.93%	ROA	15.77%	Short Interest	0.31M	Perf YTD	-3.83%
Book/sh	2.42	P/C	2.59	EPS next 5Y	0.00%	ROE	23.00%	52W High	5.75 -27.91%	Perf Year	30.76%
Cash/sh	1.60	P/FCF	11.63	EPS past 3/5Y	138.04% -	ROIC	17.81%	52W Low	2.97 39.39%	Perf 3Y	-60.26%
Dividend Est.	-	EV/EBITDA	4.68	Sales past 3/5Y	- -	Gross Margin	72.32%	Volatility	5.51% 4.79%	Perf 5Y	-
Dividend TTM	-	EV/Sales	1.89	EPS Y/Y TTM	2504.37%	Oper. Margin	38.87%	ATR (14)	0.20	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	3.56	Sales Y/Y TTM	78.05%	Profit Margin	29.37%	RSI (14)	52.43	Recom	1.33
Dividend Gr. 3/5Y	- -	Current Ratio	3.78	EPS Q/Q	117.61%	SMA20	4.86%	Beta	1.00	Target Price	8.25
Payout	0.00%	Debt/Eq	0.21	Sales Q/Q	-10.93%	SMA50	0.64%	Rel Volume	9.13	Prev Close	4.34
Employees	863	LT Debt/Eq	0.15	Earnings	Mar 27 BMO	SMA200	-0.82%	Avg Volume	31.97K	Price	4.14
IPO	Sep 26, 2022	Option/Short	No / Yes	EPS/Sales Surpr.	17.15% -12.92%	Trades		Volume	84,298	Change	-4.49%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-06-26	Initiated	BTIG Research	Buy	$8

Apr-06-26 04:00PM	Emerging Growth Research Reiterates Buy-Extended Rating on SBC Medical Group Holdings, Inc. with $9.00 Price Target Following Q4:25 Quarterly Update (ACCESSWIRE)
Apr-02-26 09:00PM	SBC Medical Group Holdings Inc (SBC) Q4 2025 Earnings Call Highlights: Strategic Expansion and ... (GuruFocus.com)
Mar-27-26 06:40AM	SBC Medical Announces Fourth Quarter and Full Year 2025 Financial Results (Business Wire)
Mar-26-26 09:17AM	What To Expect From SBC Medical Group Holdings Inc (SBC) Q4 2025 Earnings (GuruFocus.com)
Mar-24-26 04:20PM	Brompton Funds Declares Split Share Fund Distributions (TMX Newsfile)
08:00AM	Loading…
08:00AM	SBC Medical Announces Next-Generation Wellness Strategy "SBC Wellness 2.0" (Business Wire)
Mar-16-26 08:00AM	SBC Medical Announces Opening of Brand Flagship 'NEO Skin Clinic Ginza.' (Business Wire)
Mar-13-26 08:00AM	SBC Medical to Announce Q4 and Full-Year 2025 Financial Results (GlobeNewswire)
Mar-02-26 07:00AM	SBC Medical Appoints Sheng-FU Hsiao as CTO Leveraging Medical Big Data from 283 Global Locations and 6.63 Million Annual Patient Visits to Build a Scalable, AI-Driven Medical Management Infrastructure (Business Wire)
Feb-01-26 09:00PM	SBC Medical-Supported Medical Corporation Nasukai Forms Strategic Alliance with Daibi Medical Aesthetics (PR Newswire)
Jan-20-26 07:15AM	Sidoti Events, LLC's January Micro-Cap Virtual Conference (ACCESSWIRE)
Jan-07-26 12:20PM	Emerging Growth Research Maintains Buy-Extended Rating on SBC Medical Group Holdings, Inc. with $9.00 Price Target Following Strategic U.S. Market Entry (ACCESSWIRE)
09:35AM	OrangeTwist Announces Strategic Alliance with SBC Medical Group Holdings and Expansion to 24 Locations Across 6 States to Support Long-Term Growth Initiatives (Business Wire)
Jan-05-26 07:00AM	SBC Medical Accelerates Global Expansion with Strategic Investment and Alliance with a Leading U.S. MedSpa Platform OrangeTwist as Part of Broader Growth Strategy (Business Wire)
Dec-31-25 06:30AM	SBC Medical Announces Capital Strategy: Effectiveness of Form S-3 Registration Statement and Approval of Up to $20 Million Share Repurchase Program (Business Wire)
11:00PM	Loading…
Dec-12-25 11:00PM	SBC Medical Group Holdings: Announcement of Final Results of Tender Offer for Waqoo, Inc. Shares (Business Wire)
Dec-01-25 02:35PM	Emerging Growth Research Reiterates Buy-Extended Rating on SBC Medical Group Holdings, Inc. with $9.00 Price Target Following Q3:25 Results (Newsfile)
Nov-27-25 11:56AM	Japanese Bitcoin treasury stocks soar after Metaplanet raises $130m loan to buy crypto (DLNews)
Nov-18-25 12:01AM	SBC Medical Group Holdings Inc (SBC) Q3 2025 Earnings Call Highlights: Expansion and Strategic ... (GuruFocus.com)
Nov-14-25 07:47AM	SBC Medical Group Enters the Thai Market through Partnership with BLEZ (Business Wire)
07:16AM	What To Expect From SBC Medical Group Holdings Inc (SBC) Q3 2025 Earnings (GuruFocus.com)
07:00AM	SBC Medical Group Holdings Announces Third Quarter 2025 Financial Results (Business Wire)
Oct-31-25 08:00AM	SBC Medical to Announce Q3 2025 Financial Results on November 14 and Hold Earnings Call on November 17 (Business Wire)
Sep-17-25 08:00AM	SBC Medical Accelerates Multi-Brand Strategy with Hybrid Dermatology Model "Hada no Aozora Clinic" Establishment (Business Wire)
Sep-04-25 09:00AM	Emerging Growth Research Initiates Coverage on SBC Medical Group Holdings, Inc. with Buy-Extended Rating and $9.00 Price Target (Newsfile)
Sep-03-25 08:00AM	SBC Medical to Participate in the H.C. Wainwright Conference & Emerging Growth Conference in September 2025 (Business Wire)
Aug-25-25 03:00AM	SBC Medical Appoints Dr. Ewen Chee as Lead Doctor for Asia Strategy to Accelerate Global Expansion (Business Wire)
Aug-13-25 09:15AM	INSERTING and REPLACING SBC Medical Group Holdings Announces Second Quarter 2025 Financial Results (Business Wire)
06:55AM	SBC Medical Group Holdings Announces Second Quarter 2025 Financial Results (Business Wire)
Aug-01-25 08:00AM	SBC Medical to Announce Q2 2025 Financial Results and Hold Conference Call on August 13, 2025 (Business Wire)
08:00AM	Loading…
Jul-17-25 08:00AM	SBC Medical Group Acquires MB Career Lounge: JUN CLINIC Joins the Group, Strengthening Competitive Position in a Growing Market (Business Wire)
Jul-14-25 09:00AM	SBC Medical Appoints Dr. Steven R. Cohen as Medical Strategy Advisor to Accelerate Global Expansion (Business Wire)
Jul-01-25 08:00AM	SBC Medical Appoints New Chief Marketing Officer to Enhance Marketing Infrastructure and Strengthen Brand Power (GlobeNewswire)
Jun-27-25 07:30PM	SBC Medical added to membership of Russell 3000 Index (Business Wire)
Jun-23-25 01:06AM	SBC Medical Participated in 4 Investor Conferences in May and June 2025 (GlobeNewswire)
Jun-17-25 10:51PM	Participation in "The 113th Congress of Japan Society of Aesthetic Surgery," May 2025 (GlobeNewswire)
Jun-13-25 08:35AM	Life Sciences Investor Forum: Now Available for Online Viewing (GlobeNewswire)
Jun-10-25 02:38PM	Life Sciences Investor Forum Agenda Announced for June 11th-12th (GlobeNewswire)
07:30AM	Sidoti Events, LLC's Virtual June Small-Cap Conference (ACCESSWIRE)
May-28-25 01:02AM	SBC Medical Announces Attendance at Upcoming Investor Events (GlobeNewswire)
May-22-25 09:16PM	Brompton Split Banc Corp. Renews At-the-Market Equity Program (GlobeNewswire) +10.66% +18.49%
May-15-25 07:30AM	SBC Medical Group Holdings Announces First Quarter 2025 Financial Results (Business Wire)
07:00AM	SBC Medical Group Holdings Announces Approval of Share Repurchase Program and Commencement of Share Repurchases (GlobeNewswire)
May-08-25 01:08AM	SBC Medical: Scalable Profits Undermined By Governance Overhang, Still Worth A Look (Seeking Alpha)
Apr-16-25 07:00AM	Presenting on Emerging Growth Conference 81 Day 2 on April 17; Register to live stream (GlobeNewswire)
Apr-15-25 07:00AM	Presenting on Emerging Growth Conference 81 Day 1 on April 16; Register to live stream (GlobeNewswire)
Apr-14-25 08:00AM	SBC Medical Group Holdings, Inc. Purchases 5 BTC (GlobeNewswire)
Apr-09-25 03:32AM	SBC Medical to Present at the Emerging Growth Conference on April 17, 2025 (GlobeNewswire)
Mar-31-25 03:00AM	SBC Medical Accelerates Multi-Brand Strategy with 'SBC NEO Skin Clinic' Expansion (GlobeNewswire)
Mar-28-25 07:00AM	SBC Medical Group Holdings Inc. Announces Fourth Quarter and Full Year 2024 Financial Results (Business Wire) -12.53%
Mar-18-25 07:00AM	SBC Medical Group to Announce Full Year 2024 Financial Results on March 28, 2025 (Business Wire) -5.76%
Feb-12-25 07:00AM	SBC Medical Group Holdings Announces its Purchase of Bitcoin (Business Wire)
Jan-21-25 09:00AM	Sidoti Events, LLC's Virtual January Micro-Cap Conference (ACCESSWIRE)
Jan-20-25 07:00AM	SBC Medical Launches Translation App Specialized Medical Aesthetics and Strengthens 'Inbound-Focused Clinics' Initiative (Business Wire)
Dec-21-24 07:10AM	SBC Medical Group to sell two subsidiaries to CEO Yoshiyuki Aikawa (TipRanks)
Dec-20-24 07:00AM	SBC Medical Group Co., Ltd. Sells Two Subsidiaries (Business Wire)
Nov-19-24 07:00AM	SBC Medical Launches SBC Wellness, a New Solution to Help Companies Deliver Additional Health Benefits and Enhance Employee Wellbeing (Business Wire)
Nov-18-24 07:00AM	SBC Medical Group Holdings Announces Definitive Agreement to Acquire, Aesthetic Healthcare Holdings Pte. Ltd, a Multi-Unit Owner of Aesthetic Treatment Clinics in Singapore (Business Wire)
Nov-13-24 04:59PM	SBC Medical Group Holdings Inc. Reports Third Quarter 2024 Financial Results (Business Wire)
Nov-07-24 08:00AM	Healthy and Beauty Synergies: MEDIROM Healthcare Technologies and SBC Medical Group Holdings Announce Business Alliance (GlobeNewswire)
07:00AM	SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance (Business Wire)
Sep-17-24 07:19PM	SBC Medical Group Holdings and Pono Capital Two Announce Completion of Business Combination and Schedule to Begin Trading on the Nasdaq (Business Wire) -30.36%
Jan-02-24 05:05PM	Horizon Aircraft Announces Board of Directors for Post-Merger Public Company (GlobeNewswire)

SBC Medical Group Holdings, Inc. engages in management services and products to cosmetic treatment centers. The company was founded on January 20, 2023 and is headquartered in Irvine, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Aikawa Yoshiyuki	Chairman and CEO	Mar 06 '26	Sale	2.12	4,422,900	9,376,548	861,600	Mar 10 09:54 PM

Open in Screener

LFMD

LifeMD Inc

Apr 09 • 11:10AM ET

3.41

-0.06 -1.60 %

Healthcare • Health Information Services • USA • NASD

Peers: HIMS CVS TDOC AMWL DOCS LFST SEM AMED EHC CHE

| Held by: IWM VTI VXF KOMP IWO VTWO IWN IWC ITOT GSSC

Index	RUT	P/E	-	EPS (ttm)	-0.20	Insider Own	17.34%	Shs Outstand	46.66M	Perf Week	-4.62%
Market Cap	163.81M	Forward P/E	42.68	EPS next Y	0.08	Insider Trans	-0.18%	Shs Float	39.65M	Perf Month	-12.67%
Enterprise Value	133.34M	PEG	11.09	EPS next Q	-0.21	Inst Own	39.62%	Short Float	15.85%	Perf Quarter	-13.12%
Income	-9.10M	P/S	0.70	EPS this Y	-180.57%	Inst Trans	-4.16%	Short Ratio	5.70	Perf Half Y	-48.50%
Sales	234.96M	P/B	6.88	EPS next Y	139.72%	ROA	-7.82%	Short Interest	6.28M	Perf YTD	0.13%
Book/sh	0.50	P/C	4.45	EPS next 5Y	3.85%	ROE	-63.20%	52W High	15.84 -78.44%	Perf Year	-34.34%
Cash/sh	0.77	P/FCF	25.56	EPS past 3/5Y	47.57% 44.86%	ROIC	-31.55%	52W Low	2.56 33.38%	Perf 3Y	109.48%
Dividend Est.	-	EV/EBITDA	14.83	Sales past 3/5Y	17.69% 39.08%	Gross Margin	82.51%	Volatility	7.40% 8.24%	Perf 5Y	-76.45%
Dividend TTM	-	EV/Sales	0.57	EPS Y/Y TTM	63.27%	Oper. Margin	-0.61%	ATR (14)	0.28	Perf 10Y	115.43%
Dividend Ex-Date	-	Quick Ratio	1.18	Sales Y/Y TTM	10.59%	Profit Margin	-3.87%	RSI (14)	43.75	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.25	EPS Q/Q	-132.54%	SMA20	-10.70%	Beta	1.92	Target Price	9.88
Payout	-	Debt/Eq	0.27	Sales Q/Q	-27.06%	SMA50	1.79%	Rel Volume	0.54	Prev Close	3.47
Employees	389	LT Debt/Eq	0.25	Earnings	Mar 09 AMC	SMA200	-40.05%	Avg Volume	1.10M	Price	3.41
IPO	Oct 21, 2003	Option/Short	Yes / Yes	EPS/Sales Surpr.	724.05% 2.28%	Trades		Volume	175,760	Change	-1.60%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-16-26	Upgrade	Mizuho	Neutral → Outperform	$8
Jun-18-25	Reiterated	BTIG Research	Buy	$15 → $18
Dec-10-24	Initiated	Lake Street	Buy	$12
Dec-04-24	Initiated	Mizuho	Neutral	$7
Aug-23-24	Resumed	B. Riley Securities	Buy	$11
Jun-05-24	Initiated	KeyBanc Capital Markets	Overweight	$12
Nov-30-23	Initiated	Craig Hallum	Buy	$10
Jul-21-23	Initiated	Cantor Fitzgerald	Overweight	$7
Jul-03-23	Initiated	H.C. Wainwright	Buy	$9
Mar-10-22	Initiated	Colliers Securities	Buy	$14
Oct-04-21	Resumed	B. Riley Securities	Buy	$16

Show Previous Ratings

Mar-31-26 05:23PM	Novo launches $249 Wegovy subscription, undercutting Lilly as shares fall 30% (GuruFocus.com)
09:15AM	Novo Nordisk launches Wegovy subscription program (Quartz)
08:45AM	LifeMD Offers Novo Nordisk's Industry-First Wegovy Telehealth Subscription Program (GlobeNewswire)
Mar-24-26 04:05PM	LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock (GlobeNewswire)
Mar-16-26 08:00AM	LifeMD Appoints Veteran Healthcare Finance Executive as Chief Financial Officer and Expands Leadership Team (GlobeNewswire) +10.55%
06:15AM	Loading…
Mar-11-26 06:15AM	LifeMD price target raised to $10 from $9 at H.C. Wainwright (TipRanks)
Mar-09-26 11:01PM	LifeMD Inc (LFMD) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com) +25.32%
05:20PM	LifeMD, Inc. (LFMD) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:05PM	LifeMD Reports Fourth Quarter and Full Year 2025 Results (GlobeNewswire)
Mar-06-26 07:16AM	Earnings To Watch: LifeMD Inc (LFMD) Reports Q4 2025 Result (GuruFocus.com)
Mar-03-26 04:05PM	LifeMD to Participate in Two Investor Conferences During March (GlobeNewswire) +7.22%
Feb-27-26 12:39PM	Hims & Hers Expands Digital Health and Global Platform Strategy (Zacks)
Feb-23-26 08:00AM	LifeMD to Report Fourth Quarter 2025 Financial Results on March 9 (GlobeNewswire) -6.38%
Feb-17-26 07:00PM	Medifast Q4 Earnings Call Highlights (MarketBeat)
Feb-10-26 10:07PM	Quest Diagnostics Q4 Earnings Call Highlights (MarketBeat)
10:20AM	Loading…
Jan-26-26 10:20AM	Hims & Hers Scales Platform-Led Digital Healthcare Access and Care (Zacks)
Jan-09-26 02:45PM	Novo Nordisk Is Getting a Major Boost from Amazon for Its New Wegovy Pill. Does That Make NVO Stock a Buy Here? (Barchart)
Jan-06-26 08:30AM	LifeMD Announces Closing of $50 Million Revolving Credit Facility with Citizens Bank, N.A. (GlobeNewswire) +7.93%
Jan-05-26 08:42AM	Novo Nordisks Wegovy Pill Now Broadly Available Across U.S. (The Wall Street Journal) +12.03%
08:05AM	LifeMD Expands Collaboration with Novo Nordisk as Recognized Telehealth Partner Offering Newly Approved Wegovy Pill (GlobeNewswire)
Dec-30-25 12:41PM	HIMS Scales AI-Enabled Care as Platform Depth and Engagement Expand (Zacks)
Dec-26-25 08:00AM	LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock (GlobeNewswire) -12.50%
Dec-03-25 10:28AM	Hims & Hers Expands Care Scope as Prescription Platforms Evolve (Zacks)
Nov-24-25 08:00AM	LifeMD Recognized by the 2025 Deloitte Technology Fast 500 and by TIME's America's Growth Leaders of 2026 (GlobeNewswire)
Nov-20-25 11:42AM	TDOC vs. LFMD: Which Telehealth Stock Is Better for Your Portfolio? (Zacks) -7.02%
Nov-18-25 12:00AM	LifeMD Inc (LFMD) Q3 2025 Earnings Call Highlights: Strong Telehealth Growth Amidst Competitive ... (GuruFocus.com) -13.53%
Nov-17-25 05:15PM	LifeMD, Inc. (LFMD) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
04:05PM	LifeMD Reports Third Quarter 2025 Results (GlobeNewswire)
08:00AM	LifeMD to Offer Market-Leading Pricing for GLP-1 Medications Wegovy and Ozempic in Continued Collaboration with Novo Nordisk (GlobeNewswire)
Nov-14-25 06:00PM	Repare Therapeutics Inc. (RPTX) Reports Break-Even Earnings for Q3 (Zacks)
07:16AM	Loading…
07:16AM	LifeMD Inc (LFMD) Q3 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Nov-13-25 05:15PM	Co-Diagnostics, Inc. (CODX) Reports Q3 Loss, Misses Revenue Estimates (Zacks) -8.88%
Nov-10-25 05:10PM	Ascend Wellness Holdings, Inc. (AAWH) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
08:00AM	LifeMD to Participate in the BTIG Digital Health Forum (GlobeNewswire)
Nov-07-25 12:43PM	Hims & Hers Expands AI-Driven Personalized and Subscription-Based Care (Zacks)
Nov-05-25 05:15PM	LifeMD Reschedules Third Quarter 2025 Earnings Release and Conference Call to November 17 (GlobeNewswire) -6.57%
07:55AM	LifeMD Inc (LFMD) Q3 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Nov-04-25 09:15AM	LifeMD Divests Majority Interest in WorkSimpli Software, Positioning Company as a Pure-Play Virtual Care and Pharmacy Platform (GlobeNewswire) -5.57%
Oct-28-25 08:00AM	Labcorp Holdings (LH) Q3 Earnings Beat Estimates (Zacks)
Oct-27-25 01:50PM	HIMS vs. LFMD: Which Telehealth Stock Is the Better Investment Now? (Zacks)
Oct-24-25 09:00AM	Shareholders of LifeMD, Inc. Should Contact Levi & Korsinsky Before October 27, 2025 to Discuss Your Rights - LFMD (PR Newswire)
Oct-23-25 08:00AM	LifeMD to Report Third Quarter 2025 Financial Results on November 6 (GlobeNewswire)
Oct-22-25 08:00AM	LifeMD Names Dr. Tara Scott as Ambassador and Clinical Advisor for its Women's Health Program (GlobeNewswire)
Oct-20-25 10:06AM	HQY Expands Access With GLP-1 Telehealth & Direct HSA Platforms (Zacks)
03:58AM	LifeMD, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - LFMD (PR Newswire)
Oct-17-25 09:21AM	LifeMD (LFMD) Faces Lawsuit Over Alleged Concealment of Cost and Refund Woes in Key Segments, According to Hagens Berman (PR Newswire) -5.44%
Oct-15-25 02:27PM	LifeMD (LFMD) Faces Lawsuit Over Alleged Concealment of Cost and Refund Woes in Key Segments, According to Hagens Berman (Business Wire)
Oct-10-25 09:02AM	Lawsuit Targets Telehealth Firm LifeMD (LFMD) Over Alleged Misleading Statements -- Hagens Berman (PR Newswire) -5.59%
Oct-09-25 01:53PM	Hims & Hers Expands Personalized Care Access Via Telehealth Platform (Zacks)
12:40PM	Lawsuit Targets Telehealth Firm LifeMD (LFMD) Over Alleged Misleading Statements -- Hagens Berman (Newsfile)
Oct-07-25 07:13AM	LifeMD, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - LFMD (PR Newswire)
Oct-03-25 02:29PM	Lawsuit Targets Telehealth Firm LifeMD (LFMD) Over Alleged Misleading Statements -- Hagens Berman (Newsfile)
Oct-02-25 08:31AM	LifeMD, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - LFMD (PR Newswire)
Sep-30-25 03:35PM	LifeMD Expands Novo Deal, Adds Ozempic At $499 (GuruFocus.com) +5.43%
08:00AM	LifeMD Offers Ozempic at $499 Per Month through Collaboration with Novo Nordisk (GlobeNewswire)
Sep-25-25 04:06PM	LifeMD to Participate in the ROTH 4th Annual Healthcare Opportunities Conference (GlobeNewswire)
02:44PM	Lawsuit Targets Telehealth Firm LifeMD (LFMD) Over Alleged Misleading Statements -- Hagens Berman (Newsfile)
Sep-24-25 10:59AM	LifeMD, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights LFMD (Business Wire)
08:56AM	Survey shows 1/3 of GLP-1 users are lower-income (Investing.com)
Sep-23-25 04:05PM	LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock (GlobeNewswire)
Sep-19-25 08:11AM	LifeMD expands pharmacy services with non-sterile compounding capabilities (TipRanks)
08:00AM	The Weight-Loss Craze Boosted The $186 Billion Telehealth Industry. What It Means For Investors. (Investor's Business Daily)
Sep-18-25 06:17PM	Lawsuit Targets Telehealth Firm LifeMD (LFMD) Over Alleged Misleading Statements -- Hagens Berman (Newsfile) +5.76%
08:00AM	LifeMD Expands Pharmacy Services with Non-Sterile Compounding to Deliver Personalized, Cost-Efficient Therapies at Scale (GlobeNewswire)
Sep-16-25 08:45AM	LifeMD, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before October 25, 2025 to Discuss Your Rights - LFMD (PR Newswire)
Sep-09-25 06:24PM	Lawsuit Targets Telehealth Firm LifeMD (LFMD) Over Alleged Misleading Statements -- Hagens Berman (PR Newswire)
07:45AM	Important Notice to Long-Term shareholders of LifeMD, Inc. (LFMD): Grabar Law Office is Investigating Claims on Your Behalf (Newsfile)
Sep-08-25 11:10AM	Hims & Hers Expanding Partnerships to Build a Global Health Ecosystem (Zacks)
Aug-28-25 08:00AM	LifeMD to Participate in Three Investor Conferences During September (GlobeNewswire)
Aug-19-25 10:01AM	Hims & Hers Fuels Growth via Market Expansion and New Care Verticals (Zacks) -6.22%
Aug-18-25 09:07AM	Novo Nordisk to offer Ozempic at $499 per month to eligible US customers (Reuters)
Aug-06-25 10:29AM	LifeMD Stock Plummets 40%. Why Weight Loss Isn't Just A Gimme. (Investor's Business Daily) -44.85%
Aug-05-25 06:05PM	LifeMD, Inc. (LFMD) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
04:05PM	LifeMD Reports Second Quarter 2025 Results (GlobeNewswire)
Aug-04-25 04:05PM	Medifast Announces Second Quarter 2025 Financial Results (Business Wire) +24.25%
09:59AM	LifeMD Inc (LFMD) Q2 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
08:00AM	LifeMD to Participate in the Canaccord Genuity 45th Annual Growth Conference (GlobeNewswire)
Jul-31-25 01:13PM	Hims & Hers Leads the Charge in AI-Powered Personalized Healthcare (Zacks)
08:00AM	LifeMD Names COO and Promotes Two Executives (GlobeNewswire)
Jul-29-25 04:05PM	LifeMD to Report Second Quarter 2025 Financial Results on August 5 (GlobeNewswire) -6.16%
Jul-21-25 04:05PM	Medifast to Announce Financial Results for the Second Quarter Ended June 30, 2025 (Business Wire)
Jul-07-25 11:53AM	Health Meets Lifestyle: How Hims & Hers Is Reshaping Everyday Wellness (Zacks)
Jun-30-25 10:11AM	Hims & Hers vs. LifeMD: Which Telehealth Stock Has More Upside? (Zacks)
Jun-28-25 09:10AM	10 Under-the-Radar Healthcare Stocks With Incredible Growth Potential (Motley Fool)
Jun-27-25 04:51AM	Novo Nordisk says WeightWatchers will sell Wegovy (Reuters Videos)
Jun-24-25 02:07PM	Teladoc (TDOC) Moves 14.4% Higher: Will This Strength Last? (Zacks)
Jun-23-25 04:05PM	LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock (GlobeNewswire)
Jun-12-25 10:36AM	HIMS' Subscriptions Power Personalized Care & Recurring Revenue Growth (Zacks)
Jun-10-25 04:27PM	Eli Lilly telehealth deals to prevent sale of compounded GLP-1s (Yahoo Finance Video)
Jun-09-25 08:00AM	LifeMD to Participate in Two Investor Conferences During June (GlobeNewswire)
Jun-02-25 03:18PM	Solventum Stock Earns RS Rating Upgrade (Investor's Business Daily) +5.24%
May-22-25 08:05AM	LifeMD Collaborates with Novo Nordisk to Launch $299 Introductory Bundle for Self-Pay Patients Prescribed Wegovy (GlobeNewswire) +6.78%
May-12-25 04:05PM	LifeMD to Participate in Three Investor Conferences During May (GlobeNewswire)
May-06-25 05:40PM	LifeMD, Inc. (LFMD) Q1 Earnings and Revenues Top Estimates (Zacks)
04:05PM	LifeMD Reports First Quarter 2025 Results and Raises Full-Year 2025 Guidance (GlobeNewswire)
May-05-25 10:14AM	LifeMD Inc (LFMD) Q1 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Apr-30-25 05:30AM	Why New Wegovy Deals Wont Restore Novo Nordisks Obesity Lead (The Wall Street Journal) -14.62%
Apr-29-25 03:19PM	Why Hims & Hers Health and LifeMD Are Skyrocketing Today (Motley Fool) +41.31%
10:30AM	Wegovy Today, Ozempic Tomorrow: Partnership With Novo Is Hims & Hers Comeback (Seeking Alpha)
08:05AM	LifeMD Announces Plans to Expand Affordable Access to Wegovy for Cash-Pay Patients (GlobeNewswire)

LifeMD, Inc. is a telehealth company, which engages in offering a portfolio of direct-to-patient products and services. The firm combines virtual medical treatment with prescription medications and over-the-counter products. It operates through the Telehealth and WorkSimpli segments. The company was founded by Justin Schreiber on May 24, 1994 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
FRIEDEMAN JESSICA	Officer	Mar 23 '26	Proposed Sale	4.64	40,000	185,700		Mar 23 10:47 AM
FRIEDEMAN JESSICA	Chief Marketing Officer	Dec 09 '25	Sale	3.61	15,000	54,158	205,000	Dec 11 05:11 PM
FRIEDEMAN JESSICA	Officer	Nov 24 '25	Proposed Sale	4.04	20,000	80,800		Nov 24 12:46 PM
Alvarez Nicholas P	Chief Acquisition Officer	Sep 10 '25	Sale	5.92	75,000	443,760	605,000	Sep 12 04:32 PM
Alvarez Nicholas P	Officer	Sep 10 '25	Proposed Sale	6.12	75,000	459,000		Sep 10 10:44 AM
Schreiber Justin	Chairman and CEO	Jul 01 '25	Sale	9.99	25,000	249,690	2,475,721	Aug 05 05:14 PM
Justin Schreiber	Chairman and CEO	Aug 01 '25	Proposed Sale	10.41	175,000	1,821,750		Aug 01 04:09 PM
Schreiber Justin	Chairman and CEO	Jul 01 '25	Sale	13.38	25,000	334,458	2,500,721	Jul 03 03:53 PM
Benathen Marc David	Chief Financial Officer	Jun 16 '25	Sale	13.09	75,000	981,945	389,554	Jun 18 06:18 PM
Benathen Marc David	Chief Financial Officer	Jun 17 '25	Sale	14.01	50,000	700,495	339,554	Jun 18 06:18 PM
Yecies Eric Harold	Chief Legal Officer & GC	Jun 13 '25	Sale	12.25	15,000	183,750	16,100	Jun 17 06:12 PM
Galluppi Stefan	Chief Innovation Officer	Jun 13 '25	Sale	12.38	85,000	1,052,657	80,449	Jun 17 05:13 PM
Stefan Galluppi	Affiliate	Jun 13 '25	Proposed Sale	12.70	85,000	1,079,500		Jun 13 06:27 PM
Schreiber Justin	Chairman and CEO	Jun 02 '25	Sale	12.47	25,000	311,655	2,525,721	Jun 04 04:45 PM
Schreiber Justin	Chairman and CEO	May 01 '25	Sale	7.53	21,995	165,684	2,553,726	May 05 06:02 PM
Schreiber Justin	Chairman and CEO	May 02 '25	Sale	7.50	3,005	22,539	2,550,721	May 05 06:02 PM
Schreiber Justin	Chairman and CEO	Apr 29 '25	Sale	7.78	50,000	389,040	2,575,721	May 01 04:47 PM
Justin Schreiber	Chairman and CEO	Apr 29 '25	Proposed Sale	8.05	125,000	1,006,250		Apr 29 04:19 PM

AIRS

Airsculpt Technologies Inc

HIMS

Hims & Hers Health Inc

TDOC

Teladoc Health Inc

TOI

Oncology Institute Inc

SBC

SBC Medical Group Holdings Inc

LFMD

LifeMD Inc

Upgrade your Finviz experience